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ABSTRACT
Ran Tao: Designs and Analysis of Two-Phase Studies, with Applications to Genetic
Association Studies
(Under the direction of Danyu Lin and Donglin Zeng)
The two-phase design is a cost-eﬀective sampling strategy when investigators are inter-
ested in evaluating the eﬀects of covariates on an outcome but certain covariates are too
expensive to be measured on all study subjects. Under such a design, the outcome of inter-
est and the covariates that are inexpensive to measure are observed for all subjects during
the ﬁrst phase, and the ﬁrst-phase information is used to select subjects for measurements
of expensive covariates during the second phase. This design greatly reduces the cost asso-
ciated with the collection of expensive covariate data and thus has been widely used in large
epidemiological studies.
In two-phase studies, if the second-phase selection depends on multiple outcomes, then
one should consider all of them simultaneously in a multivariate regression model in order to
obtain valid inference. We develop an eﬃcient likelihood-based approach to making inference
under multivariate outcome-dependent sampling. We implement a computationally eﬃcient
expectation-maximization algorithm and establish the theoretical properties of the resulting
maximum likelihood estimators. We demonstrate the superiority of the proposed methods
over standard linear regression through extensive simulation studies. We provide applications
to two large-scale sequencing studies.
In two-phase studies, the inexpensive covariates can be used to improve the design
eﬃciency of second-phase sampling and control for confounding. However, accommodat-
ing continuous inexpensive covariates that are correlated with expensive covariates is very
iii
challenging because the likelihood function involves the conditional density functions of ex-
pensive covariates given continuous inexpensive covariates. We develop a semiparametric
approach to regression analysis by approximating the conditional density functions with
B-spline sieves. We establish the theoretical properties of the resulting estimators. We
demonstrate the superiority of the proposed methods over existing ones through extensive
simulation studies. We provide applications to a large-scale whole-exome sequencing study.
Previous research on two-phase studies has largely focused on the inference procedures
rather than the design aspects of two-phase studies. An important topic of investigation is
the optimal study design when the primary interest is to estimate the regression coeﬃcients
of the expensive covariates. We derive optimal two-phase designs, which can be substantially
more eﬃcient than the current designs.
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CHAPTER 1: INTRODUCTION
In epidemiological studies, the outcomes of interest (e.g, anthropometry measurements,
lipids levels, or disease status) and demographical and environmental variables (e.g., age,
gender, and smoking status) are typically available for all subjects. However, the covariates
of main interest often involve genotyping, biomarker assay, or medical imaging and thus are
prohibitively expensive to measure for all subjects, especially in a large study. If disease
status or another discrete outcome is of primary interest, then the case-control design with
an equal number of cases and controls is the most eﬃcient one (Scott and Wild 1997). If a
continuous outcome such as height is of primary interest, then a cost-eﬀective strategy is the
extreme-tail sampling design, whereby one selectively measures the expensive covariates
only for subjects with extreme values of the primary outcome measure (Lin et al. 2013). In
either case, the eﬃciency of the design can be improved by stratifying on the inexpensive
covariates.
The case-control and extreme-tail sampling designs can be viewed as special cases of
the two-phase, outcome-dependent sampling design, which was ﬁrst introduced by White
(1982). In the ﬁrst phase of such a design, the outcomes of interest and inexpensive covari-
ates are observed for all study subjects; the information collected during the ﬁrst phase is
then used to determine which subjects to include for measurements on expensive covariates
during the second phase. This design greatly reduces the cost and other practical burdens
associated with the collection of expensive covariate data and thus has been widely used in
large epidemiological studies.
One recent example of the two-phase design is the National Heart, Lung, and Blood
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Institute (NHLBI) Exome Sequencing Project (ESP), where 4494 subjects from seven cohorts
were selected for whole-exome sequencing (Lin et al. 2013). Among these subjects, 659, 806,
and 657 were selected because of extremely high or low values of body mass index (BMI),
blood pressure (BP) adjusted for age, gender, race, BMI, and anti-hypertensive medication,
and low-density lipoprotein (LDL) adjusted for age, gender, race, and lipid medication,
respectively.
In this dissertation, we develop novel statistical methods to solve problems arising in
the design and analysis of two-phase studies, and provide applications to genetic association
studies. The outline is as follows. In Chapter 2, we conduct a comprehensive literature
review on existing methods for the designs and analysis of two-phase studies. In Chapter
3, we develop an eﬃcient likelihood-based approach to making inference under multivariate
outcome-dependent sampling. In Chapter 4, we develop eﬃcient semiparametric inference
procedures for general two-phase studies. In Chapter 5, we study optimal two-phase designs
and point out some future directions.
2
CHAPTER 2: LITERATURE REVIEW
2.1 Introduction
Let Y denote the outcome of interest, X denote the vector of expensive covariates that
is measured on a fraction of subjects in the study, Z denote the vector of inexpensive co-
variates that is potentially correlated with X, and W denote the vector of inexpensive
covariates that is known to be independent of X given Z. The data (Y,X,Z,W ) are as-
sumed to be generated from the joint distribution Pθ(Y |X,Z,W )P (X|Z)P (Z,W ), where
Pθ(Y |X,Z,W ) is a parametric regression model indexed by parameter θ, P (X|Z) is the
conditional distribution of X given Z, and P (Z,W ) is the joint distribution of Z andW .
Under the two-phase design, (Y,Z,W ) is measured for all n subjects in the ﬁrst phase,
and X is measured for a sub-sample of size n2 in the second phase. Let R indicate, by the
values 1 versus 0, whether the subject is selected for the measurement of X in the second
phase or not. The key assumption for any two-phase design is that the distribution of R
depends on (Y,X,Z,W ) only through the ﬁrst-phase data (Y,Z,W ). Under this assump-
tion, the data on X are missing at random, such that the sampling indicators (R1, . . . , Rn)
can be omitted from the likelihood function when estimating θ. Thus, the observed-data
likelihood takes the form
n∏
i=1
{
Pθ(Yi|Xi,Zi,Wi)P (Xi|Zi)
}Ri{
log
ˆ
Pθ(Yi|x,Zi,Wi)P (x|Zi)dx
}1−Ri
. (2.1)
In this chapter, we ﬁrst review existing methods developed for regression analysis of
two-phase studies with a single outcome. These methods are classiﬁed into two categories
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depending on whether they used the ﬁrst-phase information for subjects not selected during
the second-phase or not. Then, we review existing methods for multiple outcomes. Finally,
we review existing literature on design eﬃciencies of two-phase studies.
2.2 Methods for Analyzing Two-Phase Studies with a Single Outcome
2.2.1 Methods Using Second-Phase Subjects Only
If the ﬁrst-phase information is not available for subjects not selected during the second
phase, then the resulting likelihood is
∏
i:Ri=1
P (Yi,Xi|Zi,Wi, Ri = 1)
=
∏
i:Ri=1
Pθ(Yi|Xi,Zi,Wi)P (Xi|Zi)P (Ri = 1|Yi,Zi,Wi)
P (Ri = 1|Zi,Wi) , (2.2)
where P (R = 1|Z,W ) = ´ Pθ(y|x,Z,W )P (x|Z)P (R = 1|y,Z,W )dxdy. We can also
write down a conditional likelihood that does not involve P (x|Z):
∏
i:Ri=1
P (Yi|Xi,Zi,Wi, Ri = 1) =
∏
i:Ri=1
Pθ(Yi|Xi,Zi,Wi)P (Ri = 1|Yi,Zi,Wi)
P (Ri = 1|Xi,Zi,Wi) , (2.3)
where P (R = 1|X,Z,W ) = ´ Pθ(y|X,Z,W )P (R = 1|y,Z,W )dy. Note that when both
the outcome and inexpensive covariates are discrete, one can show that expression (2.3)
is the semiparametric proﬁle likelihood of θ obtained from expression (2.2) by using the
maximization process employed in Wild (1991) and Scott and Wild (1997).
Estimators Based on the Prospective Likelihood
If the second-phase sampling is completely random or depends on the inexpensive co-
variates (Z,W ) only, then P (Ri = 1|Yi,Zi,Wi) = P (Ri = 1|Zi,Wi). Therefore, P (Ri =
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1|Yi,Zi,Wi) and P (Ri = 1|Zi,Wi) cancel out in the numerator and denominator of expres-
sion (2.3), and it is eﬃcient to base inferences about θ on the prospective likelihood
∏
i:Ri=1
Pθ(Yi|Xi,Zi,Wi). (2.4)
If there are no inexpensive covariates (Z,W ) and the second-phase sampling depends
on a binary outcome, Anderson (1972) and Prentice and Pyke (1979) showed that standard
logistic regression based on the prospective likelihood (2.4) gives valid inferences for all re-
gression coeﬃcients except for the intercept. In fact, Prentice and Pyke (1979) showed that
the prospective likelihood (2.4) is the proﬁle likelihood of θ based on the conditional likeli-
hood (2.2) with the marginal distribution of X maximized out nonparametrically. Unfortu-
nately, this feature does not carry over to arbitrary regression models in general two-phase,
outcome-dependent sampling studies. If the second-phase sampling depends on the outcome
of interest, then estimators based on expressions (2.4) are generally biased.
Maximum Semiparametric Empirical Likelihood Estimator
When the outcome is continuous but the second-phase selection depends on a small
number of strata, Zhou et al. (2002) proposed a maximum semiparametric empirical likeli-
hood estimator based on maximizing expression (2.2). Suppose that the domain of Y can
be partitioned into K mutually exclusive and exhaustive strata by the known constants
−∞ = a0 < a1 < · < aK−1 < aK = ∞. A simple random sample of size nk is drawn from
the kth stratum (k = 1, . . . , K) during the second phase. Assuming further that there are
no inexpensive covariates, the conditional likelihood (2.2) can be rewritten as
K∏
k=1
nk∏
j=1
Pθ(Ykj|Xkj)P (Xkj)
F (ak)− F (ak−1)
=
K∏
k=1
nk∏
j=1
Pθ(Ykj|Xkj)
F (ak|Xkj)− F (ak−1|Xkj)
K∏
k=1
nk∏
j=1
P (Xkj)
F (ak|Xkj)− F (ak−1|Xkj)
F (ak)− F (ak−1) , (2.5)
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where (Ykj,Xkj) is the data for the jth subject in the kth stratum (k = 1, . . . , K, j =
1, . . . , nk), F (u) = P (Y ≤ u), and F (u|X) = P (Y ≤ u|X). To estimate θ, Zhou et al.
(2002) ﬁrst proﬁled the likelihood function (2.5) by ﬁxing θ and obtaining the empirical
likelihood function of P (X) over all distributions whose support contain the observed X
values. They then maximized the resulting proﬁle likelihood function with respect to θ.
Weighted Estimators
If every study subject have a positive probability of being selected during the second
phase, then the Horvitz-Thompson approach (Horvitz and Thompson 1952) commonly used
in survey sampling can be adopted (Hsieh et al. 1985, Scott and Wild 1986, Kalbﬂeisch and
Lawless 1988, Zhao and Lipsitz 1992, Whittemore 1997). If all variables had been fully ob-
served for all n subjects, then the log-likelihood function would be
∑n
i=1 logPθ(Yi|Xi,Zi,Wi).
An estimate of this quantity is obtained if we use the completely observed units only and
weight their contributions inversely according to their probability of selection, i.e.,
n∑
i=1
Ri
pii
logPθ(Yi|Xi,Zi,Wi), (2.6)
where pi = P (R = 1|Y,Z,W ). The Horvitz-Thompson estimator of θ is based on maximiz-
ing expression (2.6). It provides unbiased estimation of the overall association in all study
subjects even when the regression model is misspeciﬁed. However, the Horvitz-Thompson
estimator is ineﬃcient, especially when the inclusion probabilities are highly variable, which
is usually the case for an eﬃcient two-phase design.
Eﬃciency can be improved by modifying the sampling weights. When the regression
model is linear, Magee (1998) proposed to weight each subject selected during the second
phase by {piaα(X,Z,W )}−1 instead of pi−1, where aα(X,Z,W ) belongs to a parameterized
family of functions indexed by the vector parameter α. They showed that under certain
moment assumptions, any estimator with positive weights {piaα(X,Z,W )}−1 is consistent
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for θ. Therefore, one can chose the optimal α that minimizes a scalar variance criterion
such as the determinant or the trace of the asymptotic variance estimator. The choice of
the function aα(X,Z,W ) is up to the analyst but the obvious idea is to choose a function
that is believed to be approximately inversely proportional to the residual variance under
the sample model.
Pfeﬀermann and Sverchkov (1999) proposed another modiﬁcation. They showed that
E(Y |X,Z,W ) = E(pi
−1Y |X,Z,W , R = 1)
E(pi−1|X,Z,W , R = 1) ,
and proposed to use the weight pi−1/E(pi−1|X,Z,W , R = 1). This weight accounts only for
the aspect of the second-phase selection process that is not determined by the covariates in
the regression model. Because of the reduced variation of the weights, the resulting estimator
tends to be more powerful than the Horvitz-Thompson estimator.
2.2.2 Methods Using All Study Subjects
Pseudo-Likelihood Estimators
If the ﬁrst-phase information is available for all study subjects, then it can be utilized
to improve eﬃciency. When the second-phase sampling is completely random or depends
on the inexpensive covariates (Z,W ) only, Pepe and Fleming (1991) and Carroll and Wand
(1991) proposed to estimate θ by maximizing the likelihood
n∏
i=1
{
Pθ(Yi|Xi,Zi,Wi)
}Ri{ˆ
Pθ(Yi|x,Zi,Wi)P (x|Zi)dx
}1−Ri
, (2.7)
where P (x|Z) is estimated nonparametrically using the second-phase sample alone. If Z is
discrete, then Pepe and Fleming (1991) estimated P (x|Z) by
P̂ (x|Z) = P̂ (x|Z, R = 1) =
{
n∑
i=1
RiI(Xi = x,Zi = Z)
}/{
n∑
i=1
RiI(Zi = Z)
}
. (2.8)
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If Z contains continuous components, then Carroll and Wand (1991) estimated P (x|Z) with
kernel smoothing techniques. That is,
P̂ (x|Z) = P̂ (x|Z, R = 1) =
∑n
i=1RiI(Xi = x)K(‖Z −Zi‖/h)∑n
i=1RiK(‖Z −Zi‖/h)
, (2.9)
where K(·) is a symmetric density function and h is the bandwidth. In addition, for scaler
Z, they obtained a representation for an optimal bandwidth through a detailed analysis of
the mean-squared error of the parameter estimate.
Mean Score Estimator
When both the outcome and inexpensive covariates are discrete, Reilly and Pepe (1995)
proposed a mean score estimator (MSE). It is based on solving the estimating equation
n∑
i=1
Rilθ(Yi|Xi,Zi,Wi) +
n∑
i=1
(1−Ri)E{lθ(Yi|X,Zi,Wi)|Yi,Zi,Wi} = 0, (2.10)
where lθ(Y |X,Z,W ) = ∂ logPθ(Y |X,Z,W )/∂θ. Reilly and Pepe (1995) proposed es-
timating E{lθ(Y |X,Z,W )|Y,Z,W } for a subject not selected during the second phase
by
´
lθ(Y |x,Z,W )dP̂ (x|Y,Z), where P̂ (x|Y,Z) is the empirical distribution of X given
(Y,Z) in the second-phase sample. This purely empirical mean score approach is valid
because P (X|Y ,Z) = P (X|Y ,Z, R = 1).
Maximum Likelihood Estimators Assuming Discrete First-Phase Information
When both the outcome and inexpensive covariates are discrete, Scott and Wild (1997)
proposed estimating θ by maximizing the full likelihood (2.1). This maximum likelihood
estimator (MLE) is the most eﬃcient among all valid estimators. Breslow and Holubkov
(1997) considered the special case of logistic regression.
For continuous ﬁrst-phase data, Lawless et al. (1999) suggested to discretize them into
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a small number of strata and then use the stratum membership to select subjects in the
second phase. Speciﬁcally, suppose that the range of (Y,Z,W ) is partitioned into K strata
S1, . . . ,SK . The observed-data likelihood is
K∏
j=1
∏
i∈Dj
Pθ(Yi|Xi,Zi,Wi)g(Xi,Zi,Wi)
Qj(θ, G)nj−n2j , (2.11)
where Qj(θ, G) = Pr{(Y,X,Z,W ) ∈ Sj}, Dj = {i: (Y,X,Z,W ) ∈ Sj, Ri = 1}, n2j =
|Dj|, nj is the total number of subjects in stratum Sj, j = 1, . . . , K, and G(·) and g(·)
are the distribution and density functions corresponding to (X,Z,W ), respectively. From
expression (2.11), we see that for subjects not selected in the second phase, only the stratum
membership is used in the inference. Breslow et al. (2003) established the asymptotic prop-
erties of the corresponding MLE. Note that the discretization of ﬁrst-phase data for subjects
not selected during the second-phase entails a substantial loss of information and may even
bias parameter estimation.
Pseudo-Score Estimators
To improve eﬃciency, Chatterjee et al. (2003) proposed a pseudo-score estimator (PSE).
It allows the outcome of interest to be continuous but require the inexpensive covariates to
be discrete. This estimator of θ is based on solving the estimating equation
n∑
i=1
Rilθ(Yi|Xi,Zi,Wi)
+
n∑
i=1
(1−Ri)
´
lθ(Yi|x,Zi,Wi)Pθ(Yi|x,Zi,Wi)P (x|Zi)dx´
Pθ(Yi|x,Zi,Wi)P (x|Zi)dx = 0, (2.12)
where the left-hand side is obtained by ﬁrst taking log of expression (2.7) and then dif-
ferentiating with respect to θ. Next, one needs to ﬁnd a valid estimator of the condi-
tional probability P (x|Z). If the second-phase sampling depends on the outcome, then
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P (x|Z) 6= P (x|Z, R = 1), and one cannot use expression (2.8), as in Pepe and Fleming
(1991), to estimate P (x|Z) anymore. From Bayes's theorem, if P (x|Z, R = 1) > 0 almost
surely, then
P (x|Z) = P (x|Z, R = 1)P (R = 1|Z,W )
P (R = 1|X = x,Z,W ) , (2.13)
where P (R = 1|X = x,Z,W ) = ´ P (R = 1|y,Z,W )Pθ(y|X,Z,W )dy. Chatterjee et al.
(2003) proposed to estimate P (x|Z) by using expression (2.13), where P (x|Z, R = 1) is
estimated by expression (2.8) and P (R = 1|Z,W ) is ignored because it cancels out in the
numerator and denominator of the second term in the left-hand side of expression (2.12).
In order to accommodate continuous covariates, Chatterjee and Chen (2007) considered
the kernel smoothing approach similar to that considered by Carroll and Wand (1991). There
are, however, some complications if the second-phase sampling depends on Z. Speciﬁcally, if
Z is partitioned into a ﬁxed number of strata, such that subjects are sampled with diﬀerent
selection probabilities across diﬀerent strata during the second phase, then the discontinuity
of the selection probabilities would cause the conditional expectation function E(U |Z, R = 1)
for a random variable U to have jumps between strata, even though E(U |Z) could be contin-
uous and smooth in the whole range of Z. To account for these discontinuities, Chatterjee
and Chen (2007) proposed to apply kernel smoothing within each partition of Z separately.
However, if the second-phase sampling depends on the partitions of the residuals calculated
from the regression model relating Y to Z and W , then the corresponding partition of Z
is hard to determine. In addition, it is diﬃcult to calculate P (R = 1|X = x,Z,W ) in this
case. Consequently, the PSE method of Chatterjee and Chen (2007) is only applicable when
the second-phase sampling depends on only discrete covariates.
Maximum Estimated Likelihood Estimator
Weaver and Zhou (2005) proposed a maximum estimated likelihood estimator (MELE).
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Similar to the PSE method of Chatterjee et al. (2003), it allows the outcome of interest to
be continuous but requires the inexpensive covariates to be discrete and the second-phase
selection to depend on a small number of strata. The MELE of θ is based on maximizing
expression (2.7), where P (x|Z) is estimated by
P̂ (x|Z = zj) =
K∑
k=1
P̂k(x|Z = zj)Nk(zj)
N(zj)
. (2.14)
Here
P̂k(x|Z = zj) =
∑
i∈Sk RiI(Xi = xi,Zi = zj)∑
i∈Sk RiI(Zi = zj)
, k = 1, . . . , K, (2.15)
and Nk(zj) and N(zj) are the numbers of observations in the population and in the kth
stratum, respectively, that satisfy Z = zj. Simulation studies in Weaver and Zhou (2005)
showed that the MELE is consistently slightly less eﬃcient than the PSE. However, they
claimed that the MELE has computational advantages over the PSE.
Maximum Likelihood Estimator Assuming No Inexpensive Covariates
Both the PSE and MELE methods are statistically ineﬃcient. Song et al. (2009) and
Lin et al. (2013) considered eﬃcient estimation for two-phase studies without inexpensive
covariates. In this case, the observed-data likelihood (2.1) reduces to
n∏
i=1
{
Pθ(Yi|Xi)P (Xi)
}Ri{
log
ˆ
Pθ(Yi|x)P (x)dx
}1−Ri
. (2.16)
Song et al. (2009) and Lin et al. (2013) maximized expression (2.16) using the nonparametric
maximum likelihood estimation, where P (X) is estimated by the discrete probabilities at the
observed values ofX. We denote this MLE approach by MLE0. If the inexpensive covariates
are available for all subjects but the second-phase selection does not depend on either Z or
11
W , then the MLE0 method can be adopted by redeﬁning the expensive covariates as
(XT,ZT,W T)T and disregarding Z and W for subjects not selected in the second phase.
This data reduction approach may entail a substantial loss of information. If the second-
phase selection does depend on Z andW , then expression (2.16) no longer correctly reﬂects
the sampling mechanism, and the MLE0 method is generally biased.
Semiparametric Eﬃcient Estimator
When every study subject have a positive probability of being selected during the second
phase, Robins et al. (1995) derived the eﬃcient score function Seff for general two-phase
studies with inexpensive covariates. Deﬁne O ≡ (Y,Z,W ), which is the ﬁrst-phase infor-
mation. They showed that Seff = U(φop), where, for any function φ(o) taking values in Rd,
d is the dimension of θ,
U(φ) = U (1) + U (2)(φ),
U (1) = Rlθ(Y |X,Z,W )−RE {lθ(Y |X,Z,W )|X,Z, R = 1} ,
U (2)(φ) = −pi−1RE {(1− pi)φ(Y,Z,W )|X,Z,W }+ (1−R)φ(O),
and φop(O) is the unique solution to the functional equation
φ(O) =E {lθ(Y |X,Z,W )|O} − E
[
E {pi(O)lθ(Y |X,Z,W )|X,Z,W }
E {pi(O)|X,Z,W }
∣∣∣∣O]
− E
[
E {(1− pi(O))φ(O)|X,Z,W }
E {pi(O)|X,Z,W }
∣∣∣∣O] .
Robins et al. (1995) proposed a class of estimators based on the eﬃcient score function.
Speciﬁcally, given a correctly speciﬁed model pi(O;α) for pi(O), they considered estimators
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θ̂(φ, α̂) solving
0 = n1/2U¯(θ, φ, α̂) = n−1/2
n∑
i=1
Ui(θ, φ, α̂),
where α̂ satisﬁes
n∑
i=1
Sα,i(α̂) = 0,
Sα(α) = ∂ [R log pi(O;α) + (1−R) log {1− pi(O;α)}] /∂α.
They showed that under certain regularity conditions, the estimator θ̂(φ, α̂) is consistent
and asymptoticly normal. In addition, if φ = φop, then θ̂(φop, α̂) is asymptoticly eﬃcient.
However, because φop(O) depends on the unknown joint distribution of the data, θ̂(φop, α̂)
cannot be used as a estimator. When both the outcome and the inexpensive covariates
are discrete, Robins et al. (1995) proposed an adaptive semiparametric eﬃcient estimator
θ̂(φ̂op, α̂) by replacing the unknown φop(O) with a consistent estimator φ̂op(O). When the
outcome of interest is continuous, however, this estimator is diﬃcult to implement because
it involves numerical solution of an inﬁnite dimensional integral equation.
2.3 Methods for Analyzing Multivariate Outcome-Dependent Sampling Studies
Weighted Estimator
Similar as in the single-outcome case, if every study subject have a positive probability
of being selected during the second phase, then the Horvitz-Thompson approach can be
adopted. This estimator avoids the joint modeling of the traits and thus can handle quan-
titative, binary, and censored time-to-event traits simultaneously. It yields unbiased eﬀect
estimation and correct type I error. Such weighting methods, however, are substantially less
eﬃcient than standard linear regression ignoring the sample design (T. Lumley, personal
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communication, April 19, 2012). Eﬃciency is a major concern in genetic association studies
since many genetic eﬀects are small and the correction for multiple comparisons is extremely
severe for tens of thousands of variants. In addition, the Horvitz-Thompson approach is not
applicable to the design where not every subject has positive probability of being selected
during the second phase.
Univariate Analysis Plus Meta-Analysis
Analysis methods for two-phase designs with a single outcome, such as that of Lin et al.
(2013), may be applied to the multivariate outcome-dependent sampling design. As men-
tioned in Section 2.2.2, Lin et al. (2013) proposed a likelihood-based approach for the uni-
variate outcome-dependent sampling design. They derived eﬃcient estimators for both the
primary trait, which is used for sampling, and the secondary trait, which is not used for
sampling. Suppose that we wish to make inference on the ﬁrst trait under a multivariate
TDS design with K traits. We can analyze the ﬁrst trait as the primary trait by treating the
individuals with extreme values of the ﬁrst trait as sequenced individuals and all others as
nonsequenced individuals. We can also analyze the ﬁrst trait as a secondary trait with each
of the remaining (K − 1) traits as the primary trait. We can then combine the summary
statistics of the K analyses. This meta-analysis is not valid because it does not account for
the correlations of the K statistics caused by overlapping individuals. To avoid overlaps of
sequenced individuals, we let each individual be considered sequenced in only one analysis.
This strategy, however, will introduce bias into the univariate analysis because the selection
for one trait depends on other traits.
2.4 Design Eﬃciency of Two-Phase Studies
When the outcome is continuous and there is no inexpensive covariate, Lin et al. (2013)
showed that the design is more eﬃcient if it selects subjects with more extreme values of Y .
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Speciﬁcally, suppose that the regression model is Y = α+βX+ , where  ∼ N(0, σ2). It can
be shown that the conditional MLE is consistent and asymptotically equivalent to the full
MLE. The information for the conditional MLE is approximately the conditional variance
of the score function
X(Y − α− βG)
σ2
− E
{
X(Y − α− βG)
σ2
∣∣∣∣Y ∈ C} (2.17)
given Y ∈ C, where C is the sampling set. After tedious calculation, this information can be
expressed as
Var(Y |Y ∈ C)Var(G|Y ∈ C)/σ4 +O(β). (2.18)
This implies that the design is more eﬃcient if it selects subjects with more extreme values
of Y .
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CHAPTER 3: ANALYSIS OF SEQUENCE DATA UNDER MULTIVARIATE
TRAIT-DEPENDENT SAMPLING
3.1 Introduction
The past few years have seen progressive advances in high-throughput sequencing tech-
nologies that allow the sequencing of genomic regions for association studies. However, the
cost of performing high-throughput sequencing on a large number of individuals is still high
and will likely remain so in the near future. If a quantitative trait is of primary interest,
then a cost-eﬀective strategy is to sequence individuals with the extreme trait values. This
trait-dependent sampling (TDS) strategy can substantially increase statistical power when
compared to a random sample of the same size (Allison 1997, Page and Amos 1999, Slatkin
1999, Chen et al. 2005, Huang and Lin 2007, Lin et al. 2013).
Many sequencing studies are derived from large, population-based cohorts, such as the
Atherosclerosis Risk in Communities (ARIC) study (The ARIC Investigators 1989), Car-
diovascular Health Study (CHS) (Fried et al. 1991), and Framingham Heart Study (FHS)
(Dawber et al. 1951). In these cohorts, hundreds of traits are measured at baseline and
follow-up visits. Investigators are often interested in multiple (potentially correlated) quan-
titative traits. One may select an equal number of individuals from the upper and lower tails
of each trait distribution or select individuals from one tail of each trait distribution and
use a random sample as a common comparison group. The former design was adopted by
the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project (ESP)
Lin et al. (2013). The latter design was recently used in the Cohorts for Heart and Aging
Research in Genomic Epidemiology Targeted Sequencing Study (CHARGE-TSS) (Lin et al.
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2014).
The NHLBI ESP European American (EA) sample consists of 2538 individuals who
were selected for sequencing from six cohorts: ARIC, CHS, FHS, Coronary Artery Risk
Development in Young Adults (CARDIA) study (Friedman et al. 1988), Multi-Ethnic Study
of Atherosclerosis (MESA) (Bild et al. 2002), and Women's Health Initiative (WHI) (The
Women's Health Initiative Study Group 1998). The project contains several studies, each of
which was focused on a particular trait and some of which selected individuals with extreme
values of quantitative traits, including low-density lipoprotein (LDL) and blood pressure
(BP). The CHARGE-TSS involves three cohorts, ARIC, CHS and FHS, in which ∼200
individuals with extreme values from each of 14 traits, as well as a random sample of ∼2000
individuals, were selected for sequencing at a total of 77 genomic loci that had been identiﬁed
by genome-wide association studies (GWAS) to be associated with one or more traits (Lin
et al. 2013).
Standard linear regression analysis based on least squares (LS) estimation only uses the
sequenced individuals and treats them as if they were randomly selected from the whole
cohorts. Thus, the multivariate TDS design is ignored with this approach. If the genetic
variant of interest is independent of all the traits used in the sampling, then the LS method
has correct type I error. If the genetic variant aﬀects certain traits used in the sampling,
however, then the LS method yields biased estimates of the genetic eﬀects. The type I error
for testing the genetic eﬀect on one trait may also be inﬂated if other traits that are used in
sampling are aﬀected by the genetic variant.
Analysis methods for the univariate TDS design, such as that of Lin et al. (2013), may
be applied to the multivariate TDS design. Lin et al. (2013) analyzed the LDL data in
the NHLBI ESP by performing separate analysis in each study and combining the summary
statistics. This approach may not preserve the type I error because it cannot properly handle
sequenced individuals with extreme values in multiple traits, as elaborated in Section 3.2.
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In the CHARGE-TSS, the selection of individuals with the extreme values of the pulmonary
function was based on both the forced expiratory volume in the ﬁrst second (FEV1) and
the ratio of FEV1 to forced vital capacity (FEV1/FVC) (Lin et al. 2013). The univariate
approach is not applicable to this case because it does not allow the selection of an individual
to depend on multiple traits. Another limitation of the univariate approach is that it cannot
perform simultaneous inference on multiple traits.
In this chapter, we develop a valid and eﬃcient likelihood-based approach to making
inferences about genetic eﬀects under multivariate TDS. In our formulation, the sampling
can depend on multiple quantitative traits in any manner. Quantitative traits are related
to genetic variants and covariates through a multivariate linear regression model while the
distributions of genetic variants and covariates are unspeciﬁed. We derive the likelihood
that accounts for the TDS and utilizes all available data. The computation is challenging
due to the presence of missing trait values with arbitrary patterns, the multivariate nature
of the model, and a potentially inﬁnite-dimensional covariate distribution. We develop a
novel expectation-maximization (EM) algorithm Dempster et al. (1977) to maximize the
likelihood. We establish the consistency, asymptotic normality, and asymptotic eﬃciency
of the resulting estimators by using novel arguments to deal with the challenging issue of
partially missing trait values. We construct single-variant and gene-level association tests
(Li and Leal 2008, Madsen and Browning 2009, Price et al. 2010, Lin and Tang 2011, Wu
et al. 2011) for assessing the marginal genetic eﬀects on each trait or the joint eﬀects on any
subset of traits. We demonstrate the superiority of the proposed methods over the univariate
approach and standard linear regression through extensive simulation studies. Finally, we
provide applications to the CHARGE-TSS and NHLBI ESP data.
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3.2 Methods
Let Y ≡ (Y1, . . . , YK)T be a K × 1 vector of quantitative traits, G be a d × 1 vector of
genetic variables, and Z be a p× 1 vector of covariates (including the unit component). We
relate Y to G and Z through the multivariate linear model:
Y = βG+ γZ + , (3.19)
where β is a K × d matrix of regression parameters for the genetic eﬀects, γ is a K × p
matrix of regression parameters for the covariate eﬀects, and  is a K-variate normal random
vector with mean 0 and covariance matrix Σ. In single-variant analysis, d = 1, and G is a
scalar that codes the number of minor alleles the individual carries at the variant site under
the additive model or indicates whether the individual carries any minor allele (or two minor
alleles) at that site under the dominant (or recessive) model. In gene-level analysis for rare
variants, G is a (weighted) sum of the numbers of mutations across multiple variant sites
within a gene or the vector of genotypes for individual variants.
Under the multivariate TDS design, Y is measured on all the N individuals in the cohort
(with potential missing values), and G is only collected for a sub-sample of size n. The
selection may depend on observed Y in an arbitrary manner. Under the one-tail design used
in the CHARGE-TSS, the sequenced individuals include those with extreme values of each
quantitative trait of interest plus a random sample. Under the two-tail design used in the
NHLBI ESP, the sequenced individuals have the largest or smallest trait values. If Z contains
demographic/environmental variables and ancestry information, such as the percentage of
African ancestry or the principal components (PCs) for ancestry, which is estimated from
the GWAS marker data, then Z may potentially be available for all N individuals. If the
ancestry information is obtained from the sequence data, then Z is available only for the
n sequenced individuals. Because it is often diﬃcult to retrieve covariate information for
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nonsequenced individuals, especially when multiple cohorts are involved, we require Z to be
available only for the n sequenced individuals.
We arrange the records such that the ﬁrst n individuals are the sequenced ones and the
remaining (N − n) are the nonsequenced ones. Then the data consist of (Y obsi ,Zi,Gi) for
i = 1, . . . , n and Y obsi for i = n+1, . . . , N , where Y
obs
i is the observed part of Yi. We include
all the individuals with at least one nonmissing trait  the largest possible sample  in
the analysis. We assume that the observations on Y are missing at random. We require
Z to be completely observed for all sequenced individuals, which is the case in both the
CHARGE-TSS and NHLBI ESP.
We represent β, γ, and Σ by θ. We show in Section 3.6 that the observed-data likelihood
takes the form
n∏
i=1
[
fθ(Y
obs
i |Zi,Gi)f(Zi,Gi)
] N∏
i=n+1
ˆ
z,g
fθ(Y
obs
i |z, g)dF (z, g), (3.20)
where fθ(·|z, g) is the joint density of Y obs conditional on (Z,G) = (z, g), f(·, ·) is the
joint density of (Z,G), and F (·, ·) is the distribution function of f(·, ·). Note that we do
not assume a speciﬁc form for f(·, ·) in (3.20). Thus, f(·, ·) is inﬁnite-dimensional when
Z contains continuous covariates. We estimate f(·, ·) by the discrete probabilities at the
observed distinct values of (Zi,Gi), i = 1, . . . , n, denoted by (z1, g1), . . . , (zm, gm), m ≤ n,
and maximize the above function over other parameters. Denote the point mass at (zj, gj)
as qj, j = 1, . . . ,m. The objective function to be maximized is equivalent to
n∑
i=1
[
log fθ(Y
obs
i |Zi,Gi) + log
m∑
j=1
I {(Zi,Gi) = (zj, gj)} qj
]
+
N∑
i=n+1
log
m∑
j=1
fθ(Y
obs
i |zj, gj)qj, (3.21)
where I(·) is the indicator function.
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We present in Section 3.7.2 a novel EM algorithm for maximizing (3.21) that is compu-
tationally eﬃcient and numerically stable. In addition, we prove in Section 3.7.3 that the
resulting maximum likelihood estimators (MLEs) are consistent, asymptotically normal, and
asymptotically eﬃcient. Thus, the corresponding association tests have correct type I error
and are the most powerful of all valid tests.
Inferences about the genetic eﬀects on the traits of interest are ﬂexible under our likeli-
hood framework, as detailed in Section 3.7.4. For single-variant analysis, G is a scalar, and
β reduces to a K×1 vector. We can use the Wald, score, or likelihood ratio statistics to test
any subset of β. The Wald tests are the most eﬃcient computationally because we only need
to ﬁt the model once no matter how many and what kind of hypotheses we are interested in;
to perform the score or likelihood ratio tests, we need to obtain the restricted MLEs under
each null hypothesis. For variants with moderate minor allele frequencies (MAFs), the three
types of tests give similar results.
To perform a burden test for rare variants, we deﬁne G as the total number of mutations
among variants whose MAFs are below a pre-speciﬁed threshold, such as 1% or 5%, with
the corresponding tests denoted by T1 and T5, respectively; alternatively, we deﬁne G as a
weighted sum of the mutation counts, using weights such as those deﬁned by Madsen and
Browning (2009) to reﬂect each variant's MAF, with the corresponding test denoted by MB.
For detecting variants with opposite eﬀects on the traits, we extend the sequence kernel
association test (SKAT) (Wu et al. 2011) to the multivariate TDS setting. We can test
the null hypothesis that there is no genetic eﬀect on a particular trait or the global null
hypothesis that there is no genetic eﬀect on any trait. All our gene-level tests are based on
the score statistics, which are statistically more accurate and numerically more stable than
the Wald statistics for rare variants (Lin and Tang 2011).
Lin et al. (2013) proposed a likelihood-based approach for the univariate TDS design.
They derived eﬃcient estimators for both the primary trait, which is used for sampling, and
21
the secondary trait, which is not used for sampling. Suppose that we wish to make inference
on the ﬁrst trait under a multivariate TDS design with K traits. We can analyze the ﬁrst
trait as the primary trait by treating the individuals with extreme values of the ﬁrst trait
as sequenced individuals and all others as nonsequenced individuals. We can also analyze
the ﬁrst trait as a secondary trait with each of the remaining (K − 1) traits as the primary
trait. We can then combine the summary statistics of the K analyses. This meta-analysis
is not valid because it does not account for the correlations of the K statistics caused by
overlapping individuals. To avoid overlaps of sequenced individuals, we let each individual
be considered sequenced in only one analysis. This strategy, however, will introduce bias
into the univariate analysis because the selection for one trait depends on other traits. We
label these two methods as (a) and (b), respectively.
For the design that contains a random sample, such as the one-tail design adopted by the
CHARGE-TSS, each individual in the cohort has a positive probability of being selected.
Then the inverse probability weighting (IPW) method commonly used in survey sampling
can be adopted. The IPW method avoids the joint modeling of the traits and thus can handle
quantitative, binary, and censored traits simultaneously. It yields unbiased eﬀect estimation
and correct type I error. Such weighting methods, however, are substantially less eﬃcient
than the LS method (T. Lumley, personal communication, April 19, 2012). Eﬃciency is a
major concern in association studies since many genetic eﬀects are small and the correction
for multiple comparisons is extremely severe for tens of thousands of variants. In addition,
IPW is not applicable to the design that does not contain a random sample.
3.3 Simulation Studies
We evaluated the performance of the MLE and LS methods in extensive simulation
studies. The ARIC data in the CHARGE-TSS are more complex than the NHLBI ESP
data because the former contain more sampling traits and more sequenced individuals with
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extreme trait values than the latter. Thus, we designed our simulation studies to mimic the
ARIC data in the CHARGE-TSS.
We generated 11 traits from the multivariate linear model given in (3.19) in which G is the
number of minor alleles for a SNP with MAF of 0.1, Z is a normally distributed confounder
(representing a PC for ancestry or some other genetically related variable) with mean G
and unit variance, and the error terms are multivariate normal with mean 0, variances
1, and correlations r under compound symmetry. (The Pearson correlation between G
and Z is ∼0.17.) We generated a cohort of 9000 individuals and selected individuals for
sequencing as follows: we ﬁrst selected a random sample of 1000 individuals; we then selected
100 individuals with the largest values of Y1 from the remaining 8000 individuals; and we
continued to select 100 individuals with the largest values of Y2 from the remaining 7900
individuals, and so on, until we reached a sequenced sample of 2100 individuals. We set
β1 = 0 and considered two cases of non-zero eﬀects for the other 10 traits: Case 1. ﬁve traits
with the same eﬀect, i.e., β2 = · · · = β6 = 0.2, β7 = · · · = β11 = 0; and Case 2. six traits
with opposite eﬀects, i.e., β2 = β4 = β6 = 0.2, β3 = β5 = β7 = −0.2, β8 = · · · = β11 = 0.
The value of 0.2 for β corresponds to R2 of 0.7% and 4.0% under γ = 0 and 0.3, respectively;
the value of −0.2 corresponds to R2 of 0.7% and 0.2% under γ = 0 and 0.3, respectively.
We assessed the bias, type I error, and power of the MLE and LS methods. The nominal
signiﬁcance level α was set to 0.001. All results are based on 100,000 replicates.
Table 3.1 shows the results for trait 1 (null eﬀect) and trait 2 (positive eﬀect) in Case 1.
The MLE method provides unbiased estimation of genetic eﬀects and correct type I error.
The LS method is approximately unbiased for β1 when the confounder has no eﬀect and the
traits are strongly correlated, and it has a negative bias for β1 when there is confounding or
the traits are weakly correlated or independent. When the confounder has no eﬀect, the LS
method substantially overestimates β2. The bias is larger when the correlations are lower.
When there is confounding, the bias decreases as the correlations increase. When the traits
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are weakly correlated or independent, the LS method yields highly inﬂated type I error,
whether or not the confounder has an eﬀect. The type I error is also inﬂated when the traits
are strongly correlated and the confounder has an eﬀect. The MLE method is more powerful
than the LS method because its standardized test statistic tends to be larger. The largest
power diﬀerence is 0.188 under γ = 0.3 and r = 0.5. The MLE method always yields smaller
root mean squared error (RMSE) than the LS method (see Table 3.2).
Table 3.1: Simulation Results for Estimating the Genetic Eﬀects on Trait 1 (Null Eﬀect)
and Trait 2 (Positive Eﬀect) in Case 1, Five Traits with the Same Eﬀect
MLE LS
Trait γ r Bias SE SEE Power Bias SE SEE Power
1 0.0 0.00 0.000 0.048 0.048 0.0010 -0.018 0.059 0.060 0.0014
0.05 0.000 0.049 0.049 0.0010 -0.015 0.059 0.059 0.0012
0.10 0.000 0.050 0.049 0.0011 -0.010 0.058 0.059 0.0010
0.20 0.000 0.050 0.050 0.0010 -0.007 0.058 0.059 0.0010
0.50 0.001 0.050 0.050 0.0010 0.002 0.058 0.059 0.0008
0.3 0.00 0.000 0.044 0.044 0.0010 -0.026 0.053 0.053 0.0023
0.05 0.000 0.044 0.044 0.0008 -0.028 0.053 0.053 0.0026
0.10 0.000 0.045 0.045 0.0010 -0.032 0.052 0.053 0.0032
0.20 0.000 0.046 0.046 0.0010 -0.032 0.052 0.053 0.0031
0.50 0.000 0.048 0.048 0.0009 -0.034 0.051 0.053 0.0030
2 0.0 0.00 0.000 0.048 0.048 0.817 0.033 0.060 0.059 0.732
0.05 0.000 0.048 0.048 0.805 0.033 0.059 0.059 0.743
0.10 0.000 0.049 0.049 0.793 0.033 0.059 0.059 0.749
0.20 0.001 0.049 0.049 0.775 0.031 0.058 0.058 0.753
0.50 0.001 0.051 0.051 0.744 0.024 0.057 0.058 0.722
0.3 0.00 0.000 0.044 0.043 0.902 0.018 0.053 0.053 0.799
0.05 0.000 0.044 0.044 0.888 0.013 0.053 0.052 0.780
0.10 0.000 0.045 0.045 0.876 0.009 0.052 0.052 0.761
0.20 0.000 0.046 0.046 0.854 0.002 0.052 0.052 0.723
0.50 0.000 0.049 0.049 0.799 -0.013 0.051 0.052 0.611
NOTE: SE and SEE stand for standard error and standard error estimate, respec-
tively.
Table 3.3 shows the results for trait 1 (null eﬀect), trait 2 (positive eﬀect), and trait 3
(negative eﬀect) in Case 2. The MLE method continues to provide unbiased estimation of
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Table 3.2: Percentage of Bias and RMSE for Estimating the Genetic Eﬀects on Trait 2
(Positive Eﬀect) in Case 1, and Traits 2 (Positive Eﬀect) and 3 (Negative Eﬀect) in Case 2
Under the One-Tail Design
Case 1: trait 2 Case 2: trait 2 Case 2: trait 3
γ r Bias RMSE Bias RMSE Bias RMSE Bias RMSE Bias RMSE Bias RMSE
0.0 0.00 0.2% 0.067 16.5% 0.091 0.2% 0.069 26.0% 0.102 0.2% 0.071 22.2% 0.097
0.05 0.2% 0.068 16.5% 0.090 0.2% 0.069 24.2% 0.099 0.1% 0.072 20.5% 0.095
0.10 0.2% 0.069 16.3% 0.089 0.2% 0.070 22.4% 0.097 0.1% 0.072 18.8% 0.093
0.20 0.3% 0.070 15.5% 0.088 0.3% 0.071 19.0% 0.093 0.0% 0.072 15.5% 0.089
0.50 0.3% 0.072 12.1% 0.085 0.3% 0.071 10.2% 0.086 0.0% 0.071 7.3% 0.085
0.3 0.00 0.1% 0.061 8.9% 0.077 0.1% 0.063 18.5% 0.085 0.1% 0.064 23.3% 0.089
0.05 0.1% 0.063 6.7% 0.076 0.1% 0.064 15.4% 0.082 0.1% 0.065 23.3% 0.089
0.10 0.1% 0.063 4.7% 0.075 0.2% 0.064 12.6% 0.080 0.1% 0.065 23.3% 0.089
0.20 0.2% 0.065 1.0% 0.073 0.2% 0.066 7.4% 0.077 0.1% 0.067 22.8% 0.088
0.50 0.2% 0.069 6.6% 0.074 0.2% 0.069 4.1% 0.075 0.0% 0.068 19.7% 0.084
NOTE: RMSE stands for root mean squared error.
genetic eﬀects and correct type I error. The LS method tends to overestimate the eﬀect on
trait 2 and underestimate the eﬀect on trait 3, and the bias can be as high as 26%, which
is higher than in Case 1. The LS method also has inﬂated type I error (as high as 80%)
when there is confounding. When the confounder has no eﬀect, the LS method generally has
correct type I error, although it is not as powerful as the MLE method; the power diﬀerences
are larger when the correlations are higher, which is opposite to what we ﬁnd in Case 1. The
MLE method always yields smaller root mean squared error (RMSE) than the LS method
(see Table 3.2). For both Case 1 and Case 2, we conducted other simulations with larger
genetic eﬀects and lower MAFs or with 10% random missingness in all traits. The results
are similar to those of Tables 3.1 and 3.3 and thus not shown.
Due to the presence of a random sample, it was possible to evaluate the IPW method.
We set the weights for individuals with extreme trait values at 1 and set the weights for
individuals in the random sample at 9. These weights are not exactly equal to the inverse
selection probabilities, which are diﬃcult to calculate under the sequential selection mech-
anism, but the approximations are good enough for our illustration. The results for Case
1 and Case 2 are summarized in Table 3.4. Comparing Table 3.4 with Tables 3.1 and 3.3,
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Table 3.3: Simulation Results for Estimating the Genetic Eﬀects on Trait 1 (Null Eﬀect),
Trait 2 (Positive Eﬀect), and Trait 3 (Negative Eﬀect) in Case 2, Six Traits with Opposite
Eﬀects
MLE LS
Trait γ r Bias SE SEE Power Bias SE SEE Power
1 0.0 0.00 0.000 0.050 0.050 0.0011 -0.003 0.061 0.061 0.0010
0.05 0.000 0.050 0.050 0.0011 -0.003 0.061 0.061 0.0011
0.10 0.000 0.050 0.050 0.0010 -0.003 0.061 0.061 0.0010
0.20 0.000 0.051 0.051 0.0010 -0.002 0.060 0.060 0.0009
0.50 0.000 0.050 0.050 0.0010 -0.001 0.060 0.060 0.0009
0.3 0.00 0.000 0.045 0.045 0.0011 -0.008 0.054 0.054 0.0012
0.05 0.000 0.045 0.045 0.0010 -0.011 0.054 0.054 0.0011
0.10 0.000 0.046 0.046 0.0011 -0.014 0.053 0.054 0.0013
0.20 0.000 0.047 0.046 0.0010 -0.020 0.054 0.054 0.0018
0.50 0.000 0.049 0.049 0.0010 -0.025 0.052 0.053 0.0018
2 0.0 0.00 0.000 0.049 0.049 0.792 0.052 0.062 0.061 0.787
0.05 0.000 0.049 0.049 0.782 0.048 0.062 0.061 0.780
0.10 0.001 0.050 0.049 0.773 0.045 0.061 0.060 0.772
0.20 0.001 0.050 0.050 0.762 0.038 0.060 0.060 0.751
0.50 0.001 0.051 0.050 0.753 0.020 0.059 0.059 0.668
0.3 0.00 0.000 0.044 0.044 0.888 0.037 0.055 0.054 0.859
0.05 0.000 0.045 0.045 0.875 0.031 0.054 0.054 0.840
0.10 0.000 0.046 0.046 0.862 0.025 0.054 0.054 0.818
0.20 0.000 0.047 0.047 0.842 0.015 0.053 0.053 0.771
0.50 0.000 0.049 0.049 0.798 -0.008 0.052 0.053 0.622
3 0 0.00 0.000 0.050 0.050 0.754 -0.044 0.060 0.061 0.759
0.05 0.000 0.051 0.051 0.746 -0.041 0.060 0.061 0.750
0.10 0.000 0.051 0.051 0.742 -0.038 0.059 0.061 0.741
0.20 0.000 0.051 0.051 0.734 -0.031 0.059 0.060 0.718
0.50 0.000 0.050 0.050 0.747 -0.015 0.058 0.059 0.631
0.3 0.00 0.000 0.045 0.045 0.873 -0.047 0.053 0.054 0.895
0.05 0.000 0.046 0.046 0.861 -0.047 0.053 0.054 0.900
0.10 0.000 0.046 0.046 0.850 -0.047 0.053 0.054 0.904
0.20 0.000 0.047 0.047 0.831 -0.046 0.052 0.054 0.907
0.50 0.000 0.048 0.048 0.798 -0.039 0.051 0.054 0.888
NOTE: SE and SEE stand for standard error and standard error esti-
mate, respectively.
we observe that although the IPW method preserves the type I error, it is substantially less
powerful than the MLE and LS methods.
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Table 3.4: Simulation Results for the IPW Method Under the One-Tail Design
Case 1 Case 2
Trait 1 Trait 2 Trait 1 Trait 2 Trait 3
γ r Bias Power Bias Power Bias Power Bias Power Bias Power
0.0 0.00 -0.001 0.0011 0.010 0.366 0.000 0.0011 0.012 0.360 -0.009 0.345
0.05 0.000 0.0010 0.011 0.370 0.000 0.0010 0.011 0.356 -0.008 0.341
0.10 0.002 0.0011 0.012 0.373 0.000 0.0011 0.011 0.353 -0.007 0.336
0.20 0.004 0.0011 0.013 0.376 0.001 0.0011 0.009 0.347 -0.005 0.326
0.50 0.009 0.0010 0.013 0.369 0.002 0.0011 0.006 0.325 -0.001 0.302
0.3 0.00 -0.003 0.0011 0.008 0.411 -0.001 0.0010 0.011 0.412 -0.010 0.406
0.05 -0.002 0.0010 0.009 0.411 -0.001 0.0010 0.010 0.406 -0.009 0.401
0.10 -0.001 0.0011 0.009 0.409 -0.001 0.0011 0.009 0.398 -0.009 0.396
0.20 0.001 0.0011 0.009 0.404 -0.001 0.0011 0.008 0.385 -0.007 0.387
0.50 0.003 0.0010 0.008 0.384 -0.001 0.0011 0.003 0.349 -0.004 0.357
We also conducted simulation studies under the two-tail design. Speciﬁcally, we generated
the cohort in the same manner as in the previous simulation studies but sequentially selected
95 individuals from the upper and lower tails of each trait distribution to reach a sequenced"
sample of 2090 individuals. The results that are analogous to those shown in Tables 3.1
and 3.3 are summarized in Tables 3.5 and 3.6. The MLE method continues to perform
well. Because the two-tail sampling is more extreme than the one-tail sampling used in the
previous simulation studies, the LS method tends to yield more bias. The loss of power by
the LS method compared to the MLE method tends to be more severe under the two-tail
design than under the one-tail design (with maximal diﬀerences of 0.583 vs. 0.188). In
addition, the MLE method is generally more powerful under the two-tail design than under
the one-tail design (with the power diﬀerence being as high as 0.184).
We conducted additional simulation studies under simple random sampling. We gener-
ated the cohort in the same manner as before but selected a simple random sample of 2100
individuals. The LS method is valid in this setting. The power is approximately 0.61 for
all traits with non-zero eﬀects (positive or negative) in both Case 1 and Case 2 with any
combination of γ and r. When comparing with the power estimates for trait 2 in Tables 3.1
and 3.5 and traits 2 and 3 in Tables 3.3 and 3.6, we see that the two multivariate TDS
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Table 3.5: Simulation Results for Estimating the Genetic Eﬀects on Trait 1 (Null Eﬀect)
and Trait 2 (Positive Eﬀect) in Case 1 Under the Two-Tail Design
MLE LS
Trait γ r Bias SE SEE Power Bias SE SEE Power
1 0.0 0.00 0.000 0.046 0.045 0.0010 0.000 0.067 0.067 0.0009
0.05 0.000 0.046 0.046 0.0011 0.018 0.066 0.066 0.0014
0.10 0.000 0.046 0.046 0.0011 0.033 0.066 0.067 0.0026
0.20 0.000 0.045 0.045 0.0010 0.058 0.069 0.070 0.0066
0.50 0.000 0.042 0.041 0.0010 0.098 0.078 0.078 0.0198
0.3 0.00 0.000 0.044 0.044 0.0010 -0.027 0.063 0.064 0.0017
0.05 0.000 0.046 0.046 0.0010 -0.017 0.061 0.062 0.0013
0.10 0.000 0.046 0.046 0.0011 -0.011 0.061 0.062 0.0011
0.20 0.000 0.046 0.046 0.0010 0.000 0.062 0.063 0.0008
0.50 0.000 0.043 0.043 0.0010 0.017 0.069 0.071 0.0010
2 0.0 0.00 0.001 0.046 0.046 0.856 0.085 0.066 0.066 0.844
0.05 0.001 0.046 0.046 0.856 0.098 0.066 0.066 0.886
0.10 0.001 0.046 0.046 0.860 0.111 0.066 0.067 0.911
0.20 0.001 0.046 0.046 0.864 0.125 0.068 0.068 0.928
0.50 0.000 0.043 0.043 0.909 0.135 0.076 0.076 0.865
0.3 0.00 0.000 0.045 0.045 0.874 0.047 0.061 0.062 0.754
0.05 0.000 0.046 0.046 0.864 0.049 0.061 0.062 0.767
0.10 0.000 0.046 0.046 0.857 0.050 0.061 0.062 0.775
0.20 0.001 0.046 0.046 0.850 0.053 0.062 0.063 0.776
0.50 0.000 0.045 0.045 0.875 0.053 0.067 0.068 0.660
NOTE: SE and SEE stand for standard error and standard error estimate, respec-
tively.
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Table 3.6: Simulation Results for Estimating the Genetic Eﬀects on Trait 1 (Null Eﬀect),
Trait 2 (Positive Eﬀect), and Trait 3 (Negative Eﬀect) in Case 2 Under the Two-Tail Design
MLE LS
Trait γ r Bias SE SEE Power Bias SE SEE Power
1 0.0 0.00 0.000 0.046 0.046 0.0010 0.000 0.065 0.066 0.0009
0.05 0.000 0.046 0.046 0.0010 0.000 0.065 0.066 0.0010
0.10 0.000 0.046 0.046 0.0011 -0.001 0.066 0.066 0.0011
0.20 0.000 0.044 0.044 0.0010 -0.001 0.070 0.070 0.0008
0.50 0.000 0.043 0.043 0.0011 -0.006 0.075 0.076 0.0009
0.3 0.00 0.000 0.045 0.045 0.0010 -0.011 0.064 0.064 0.0010
0.05 0.000 0.045 0.045 0.0009 -0.014 0.063 0.064 0.0010
0.10 0.000 0.045 0.045 0.0009 -0.018 0.063 0.064 0.0012
0.20 0.000 0.045 0.045 0.0011 -0.025 0.065 0.066 0.0016
0.50 0.000 0.042 0.042 0.0009 -0.038 0.070 0.072 0.0021
2 0.0 0.00 0.001 0.046 0.046 0.860 0.084 0.065 0.066 0.846
0.05 0.001 0.046 0.046 0.861 0.080 0.066 0.066 0.826
0.10 0.001 0.046 0.046 0.863 0.075 0.066 0.067 0.800
0.20 0.001 0.045 0.045 0.874 0.064 0.067 0.068 0.725
0.50 0.000 0.042 0.042 0.924 0.028 0.075 0.076 0.386
0.3 0.00 0.000 0.045 0.045 0.869 0.064 0.062 0.063 0.824
0.05 0.000 0.046 0.046 0.860 0.056 0.062 0.063 0.791
0.10 0.001 0.046 0.046 0.856 0.048 0.062 0.063 0.752
0.20 0.001 0.046 0.046 0.853 0.033 0.062 0.063 0.656
0.50 0.000 0.044 0.044 0.890 -0.007 0.067 0.069 0.307
3 0.0 0.00 -0.001 0.046 0.046 0.861 -0.085 0.066 0.066 0.846
0.05 -0.001 0.046 0.046 0.863 -0.081 0.066 0.066 0.830
0.10 -0.001 0.046 0.045 0.868 -0.077 0.066 0.067 0.806
0.20 -0.001 0.045 0.045 0.878 -0.068 0.068 0.068 0.739
0.50 0.000 0.042 0.042 0.931 -0.043 0.075 0.076 0.457
0.3 0.00 0.000 0.045 0.045 0.870 -0.082 0.062 0.063 0.882
0.05 0.000 0.046 0.046 0.864 -0.083 0.062 0.063 0.884
0.10 0.000 0.046 0.046 0.859 -0.082 0.062 0.063 0.882
0.20 0.000 0.046 0.046 0.861 -0.080 0.063 0.064 0.864
0.50 0.000 0.044 0.044 0.900 -0.068 0.068 0.070 0.713
NOTE: SE and SEE stand for standard error and standard error esti-
mate, respectively.
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Table 3.7: Simulation Results for Estimating the Genetic Eﬀects on Trait 1 (Null Eﬀect)
and Trait 2 (Positive Eﬀect) in Case 1 When the Traits Follow Multivariate T Distributions
Trait 1 Trait 2
MLE LS MLE-INV MLE LS MLE-INV
ν Bias Power Bias Power Bias Power Bias Power Bias Power Bias Power
5 0.021 0.0023 -0.019 0.0012 0.013 0.0017 -0.052 0.319 0.010 0.158 -0.078 0.358
10 0.015 0.0015 -0.025 0.0015 0.009 0.0012 -0.023 0.648 0.012 0.431 -0.049 0.631
15 0.010 0.0012 -0.026 0.0018 0.007 0.0010 -0.015 0.744 0.013 0.551 -0.038 0.725
20 0.008 0.0011 -0.028 0.0018 0.005 0.0010 -0.011 0.788 0.013 0.612 -0.032 0.771
30 0.005 0.0010 -0.028 0.0023 0.003 0.0009 -0.007 0.826 0.013 0.672 -0.026 0.812
designs are much more eﬃcient than simple random sampling.
To assess the robustness to the normality assumption, we simulated data in the setup
of Case 1 under the one-tail design but let  follow a multivariate t distribution tν(0,Σ),
where Σ is the scale matrix, and ν is the degrees of freedom. We set γ = 0.3 and r = 0.05.
We added a variation of the MLE method that applies the inverse normal transformation
to the trait values, which is referred to as MLE-INV. The results are summarized in Table
3.7. The MLE method has appreciable bias and inﬂated type I error for trait 1 (null eﬀect)
when ν is small but performs reasonably well when ν is moderate or large. The MLE-INV
method has better control of the type I error than the MLE method when ν is small. The
LS method is biased and its performance worsens as ν increases.
To compare our multivariate approach with the univariate approach of Lin et al. (2013),
we simulated a cohort of 10,000 individuals with two traits. We set the genetic variable to
be the number of minor alleles for a SNP with MAF of 0.1, the eﬀect sizes at 0.2 and 0 for
the two traits; we did not include any confounder in the model. We adopted the two-tail
design by sequentially selecting 250 individuals from the upper and lower tails of the two
trait distributions. We used score tests for both approaches. We set the nominal signiﬁcance
level at 0.001 and varied the correlation between the two traits and the proportion of random
missingness for each trait. As shown in Table 3.8, the univariate approach has inﬂated type
I error, which is caused by the underestimation of the variance in method (a) and the bias
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Table 3.8: Simulation Results for Comparing the Multivariate and Univariate Approaches
Multivariate Univariate (a) Univariate (b)
Trait r % Missing Mean SE SEE Power Mean SE SEE Power Mean SE SEE Power
1 0.0 0 114.5 24.0 24.1 0.935 120.0 25.7 25.0 0.936 118.9 25.0 25.5 0.931
20 103.2 22.8 22.9 0.892 107.8 24.3 23.7 0.898 107.0 23.7 24.1 0.885
0.1 0 114.5 24.0 24.1 0.934 120.3 25.9 25.1 0.936 119.0 25.1 25.5 0.926
20 103.3 22.8 22.9 0.895 108.1 24.3 23.7 0.899 107.1 23.7 24.2 0.888
0.3 0 114.5 23.9 24.1 0.934 122.7 26.6 25.3 0.936 120.1 25.3 25.9 0.925
20 103.6 22.9 22.9 0.894 109.7 25.0 23.9 0.900 107.7 24.1 24.5 0.879
0.5 0 114.9 24.1 24.1 0.934 129.6 29.2 26.2 0.937 122.4 26.7 27.1 0.901
20 104.6 23.2 23.0 0.895 114.5 26.8 24.5 0.904 109.3 25.0 25.3 0.861
0.7 0 117.0 24.4 24.2 0.941 149.6 34.6 28.7 0.949 125.4 30.0 30.6 0.802
20 108.0 23.5 23.3 0.910 127.7 30.5 26.3 0.922 112.1 27.2 27.5 0.792
2 0.0 0 0.0 24.2 24.3 0.0009 0.0 25.8 24.8 0.0017 0.0 24.2 24.2 0.0009
20 0.0 23.1 23.0 0.0009 0.0 24.5 23.5 0.0015 0.0 23.0 23.0 0.0009
0.1 0 0.0 24.3 24.3 0.0010 0.0 26.0 24.8 0.0017 -2.4 24.2 24.2 0.0011
20 0.0 23.1 23.0 0.0010 0.1 24.6 23.5 0.0016 -1.8 23.0 23.0 0.0011
0.3 0 0.0 24.5 24.5 0.0010 0.1 27.1 25.3 0.0021 -7.6 24.2 24.2 0.0017
20 0.0 23.3 23.3 0.0009 0.1 25.5 23.9 0.0017 -5.8 23.0 23.0 0.0014
0.5 0 0.1 25.1 25.1 0.0010 0.1 29.7 26.6 0.0035 -14.4 24.3 24.4 0.0032
20 0.0 23.8 23.8 0.0011 0.1 27.3 24.8 0.0027 -10.7 23.1 23.1 0.0022
0.7 0 0.1 26.1 26.2 0.0010 0.1 34.7 29.3 0.0053 -24.9 25.3 25.5 0.0096
20 0.1 24.8 24.8 0.0011 0.2 30.9 26.8 0.0039 -17.5 23.8 23.9 0.0047
NOTE: SE and SEE stand for the standard error and standard error estimate of the score statistic.
in method (b). The inﬂation increases as the correlation between the two traits becomes
stronger. There is power loss in (b) as compared to the multivariate approach, which is
caused by the larger variances of the test statistics. The power diﬀerence is larger when the
correlation is higher and is not aﬀected much by the level of missingness.
3.4 CHARGE-TSS ARIC Data
We considered the ARIC data in the CHARGE-TSS. As described, a random sample
plus individuals with extreme values for 11 traits were selected from ∼9000 ARIC whites
who provided informed consent for use of their genetic data and had suﬃcient DNA for
sequencing. The selected individuals were sequenced for 77 genomic loci that had previously
been found to be associated with one or more of 14 traits. (Three traits were not used for
sampling in the ARIC data.) After quality control (QC), the genotype data included 31,813
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SNPs and 2003 individuals. Details for the design, sample selection criteria, genotype QC,
and annotation can be found in Lin et al. (2013).
We removed individuals without PCs (calculated from GWAS data) and obtained 9103
individuals, among whom 1927 were sequenced. Table 3.9 shows the number of individuals
with nonmissing trait values in the cohort, the speciﬁc sampling strategy, and the achieved
number of extreme cases for sequencing, as well as that number after QC for each of the 11
traits. (Note that the numbers of extreme cases for all traits may add up to be greater than
n since some individuals may have extreme values for multiple traits.) Of the 11 traits used
for sampling, stroke is an age-at-onset trait that cannot be incorporated into our model. We
treated the 60 individuals who were selected solely due to stroke as nonsequenced individuals.
As noted before, the pulmonary function trait comprised two traits  FEV1 and FEV1/FVC
 such that the total number of traits entering into the analysis remained at 11. C-reactive
protein (CRP) and retinal venule diameter have about 20% missingness in the whole cohort,
while all the other traits have less than 5% missingness.
In the CHARGE-TSS, the selections for certain traits were based on the residuals of the
original values adjusted for various covariates. For those traits, we used the residuals in the
analysis. Most of the traits are positively correlated, and there is no pairwise correlation less
than −0.15. The correlations are 0.56 between fast insulin and body mass index (BMI), 0.49
between the two pulmonary function traits, 0.30 between BMI and CRP, and 0.22 between
fast insulin and hematocrit, as well as between fast insulin and CRP. All the other positive
correlations are well below 0.2, and many of them are essentially 0 (see Table 3.10). We
included age, gender, study centers, and the top ﬁve PCs as covariates.
We focused on BMI. We restricted the single-variant analysis to SNPs with MAFs larger
than 5% and ended up with 2971 SNPs. We chose the additive genetic model. Table 3.11
shows the top 10 SNPs for the MLE method and the corresponding LS results. The LS
method consistently yields larger eﬀect estimates for SNPs with positive eﬀects and smaller
32
Table 3.9: Summary of the ARIC Data in the CHARGE-TSS
No. (%) of non- Sampling No. sequenced
Trait missing values strategy (No. after QC)
ECG PR interval 8996 (98.82) high residual 94 (92)
ECG QRS interval 9053 (99.45) high residual 90 (89)
Blood pressure 9091 (99.87) high/low residual 93 (89)
Body mass index 9095 (99.91) high 90 (79)
Fasting insulin 8896 (97.73) high 94 (94)
C-reactive protein 7211 (79.22) high residual 93 (90)
Hematocrit 9071 (99.65) low residual 97 (85)
Retinal venule diameter 7099 (77.99) high 156 (154)
Carotid wall thickness 8725 (95.85) high 91 (87)
Pulmonary: FEV1 8958 (98.41) low 186 (185)
Pulmonary: FEV1/FVC 8956 (98.39)
Stroke early onset 74 (70)
Random sample 946 (913)
Total 9103 (100.00) 2003 (1927)
NOTE: For the sampling strategy, high" (low") means sampling from the
upper (lower) tail of the trait distribution; residual" indicates that the sampling
is based on the residuals of the original values adjusted for covariates.
eﬀect estimates for SNPs with negative eﬀects. This is similar to what we ﬁnd in most
scenarios under Case 2 in the simulation studies. As shown in Figure 3.1 of the Supplemental
Material, the p-values for the MLE and LS methods are similar.
In gene-level analysis of rare variants, we considered functional coding variants, i.e., non-
synonymous, splicing, and stop-gain variants, and ended up with a total of 2360 variants. We
removed any targeted region with minor allele count (MAC)  the number of individuals
with at least one mutation  less than ﬁve. For MB and SKAT tests, we only included
variants with MAFs less than 5%. Table 3.12 shows the results for the top ﬁve targeted
regions in each of the four types of tests based on the MLE method. We also performed
gene-level tests of the global null hypothesis that there is no genetic eﬀect on any trait. Table
3.13 shows the results for the top ﬁve targeted regions in each of the four types of tests. It
would be worthwhile to follow up the regions identiﬁed in Tables 3.12 and 3.13 in larger
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Figure 3.1: Plot of the p-values for the MLE versus LS methods in the analysis of the BMI
data in the CHARGE-TSS ARIC sample. SNPs with MAFs greater than 5% are included.
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Table 3.10: Pairwise Correlations of the 11 Traits Used for Sampling in the CHARGE-TSS
ARIC Data
PR QRS BP BMI FI CRP HEMA EYE IMT FEV1
QRS 0.04
BP 0.02 0.04
BMI 0.00 0.00 0.00
FI 0.00 −0.04 0.12 0.56
CRP −0.01 −0.03 0.04 0.30 0.22
HEMA −0.02 −0.02 0.11 0.13 0.22 0.06
EYE 0.00 −0.04 −0.05 0.03 0.04 0.08 0.18
IMT 0.02 0.01 0.08 0.08 0.07 0.08 0.05 0.07
FEV1 0.01 0.03 −0.07 −0.04 −0.11 −0.14 −0.05 −0.05 −0.06
FEV1/FVC 0.02 0.04 −0.02 0.17 0.15 0.05 0.01 −0.02 −0.01 0.49
NOTE: PR: ECG PR interval; QRS: ECG QRS interval; BP: blood pressure; BMI:
body mass index; FI: fast insulin; CRP: C-reactive protein; HEMA: hematocrit;
EYE: retinal venule diameter; IMT: carotid wall thickness; FEV1: forced expiratory
volume in 1 second; FVC: forced vital capacity.
samples.
3.5 NHLBI ESP EA Data
The NHLBI ESP EA data consist of the six cohorts mentioned previously and include
four types of study designs. The ﬁrst study is a TDS study consisting of 872 individuals
who were selected from the upper and lower tails of the LDL and BP distributions. The
second study is a random sample of 721 individuals with measurements on a common set of
phenotypes; this study is referred to as the deeply phenotyped reference (DPR). The third
study is a case-control study of early myocardial infarction (MI) consisting of 220 cases and
390 controls. The fourth study is a case-only study of stroke consisting of 335 individuals
with ischemic stroke. Exome sequencing was performed on the selected individuals at the
University of Washington and the Broad Institute. We implemented the genotype QC steps
described by Lin et al. (2013) and obtained 1,281,645 variants.
In the TDS study, we excluded individuals (either sequenced or nonsequenced) who were
35
Table 3.11: Top 10 SNPs in the Single-Variant Analysis of the BMI Data in the CHARGE-
TSS ARIC Sample
MLE LS
Variant ID Gene MAF Est SE p-value Est SE p-value
chr02:000649384 TMEM18 2.87E-01 1.12E-01 3.21E-02 4.89E-04 1.34E-01 4.04E-02 9.07E-04
chr02:000669959 TMEM18 2.98E-01 −1.06E-01 3.19E-02 8.79E-04 −1.34E-01 4.11E-02 1.09E-03
chr12:000547464 NINJ2 6.43E-02 −1.96E-01 5.92E-02 8.98E-04 −2.47E-01 7.41E-02 8.38E-04
chr01:068340029 WLS 4.94E-01 −9.41E-02 2.86E-02 9.93E-04 −1.17E-01 3.65E-02 1.36E-03
chr02:000648937 TMEM18 2.95E-01 1.01E-01 3.23E-02 1.72E-03 1.19E-01 4.07E-02 3.31E-03
chr02:000648595 TMEM18 3.00E-01 9.75E-02 3.19E-02 2.27E-03 1.15E-01 4.04E-02 4.43E-03
chr02:000645222 TMEM18 1.12E-01 −1.44E-01 4.74E-02 2.47E-03 −1.71E-01 5.96E-02 4.09E-03
chr02:000649218 TMEM18 2.60E-01 1.01E-01 3.36E-02 2.59E-03 1.23E-01 4.24E-02 3.76E-03
chr02:000647954 TMEM18 2.95E-01 9.83E-02 3.27E-02 2.61E-03 1.15E-01 4.10E-02 4.97E-03
chr02:000648157 TMEM18 2.99E-01 9.34E-02 3.20E-02 3.53E-03 1.10E-01 4.04E-02 6.35E-03
NOTE: Variant ID is in chromosome:position format, where the positions are based on the reference
human genome (NCBI Genome Build 36, 2006). Est and SE stand for the genetic eﬀect estimate and
standard error, respectively.
not eligible for either the LDL or BP selection. In the FHS, which contains related individu-
als, we removed one individual from each pair of ﬁrst- or second-degree relatives. The actual
sample selections for LDL and BP were based on the residuals rather than the original val-
ues. We used the LDL residuals (log-transformed LDL values adjusted for age, age-squared,
gender, and lipid medication) and BP residuals (mean of the residuals for diastolic and
systolic BPs adjusted for age, gender, BMI, and anti-hypertensive medication) as the trait
values in the analysis. We considered LDL as the trait of interest and removed individuals
with missing LDL values in the DPR, MI, and stroke studies. Note that individuals with
missing LDL or BP values (but not both) were still included in the analysis of the TDS
study. Table 3.14 summarizes the sample sizes of the four studies in each cohort after QC.
In the TDS study, we used both the MLE and LS methods to analyze LDL. For case-
control and case-only studies with rare diseases, standard linear regression analysis of sec-
ondary quantitative traits conditional on the disease status yields approximately correct
results (Lin and Zeng 2009). Because early MI and ischemic stroke are relatively rare, we
performed standard linear regression in the MI (adjusted for the MI status), stroke, and DPR
studies. We included cohorts and sequencing centers/targets as covariates. We performed
36
Table 3.12: Top Five Targeted Regions for the T1, T5, MB, and SKAT Tests in the Analysis
of the BMI Data Using the MLE Method in the CHARGE-TSS ARIC Sample
Test Region MAC MLE p-value LS p-value
T1 chr05:087819438-088215292 6 1.90E-03 2.21E-01
chr01:168853417-168975265 6 3.52E-03 4.59E-01
chr12:111338491-111436622 8 1.73E-02 5.37E-01
chr05:156830995-156936446 60 1.84E-02 2.16E-01
chr07:100054874-100079499 48 2.59E-02 2.88E-02
T5 chr05:087819438-088215292 6 1.90E-03 2.21E-01
chr01:168853417-168975265 6 3.52E-03 4.59E-01
chr12:111338491-111436622 8 1.73E-02 5.37E-01
chr07:100054874-100079499 48 2.59E-02 2.88E-02
chr10:104579177-104619322 23 2.90E-02 9.45E-01
MB chr13:109599195-109758700 18 2.32E-02 2.52E-01
chr06:025857845-025987550 57 2.78E-02 4.67E-01
chr10:104579177-104619322 6 4.64E-02 1.85E-01
chr11:046720500-046832766 6 7.68E-02 8.90E-01
chr12:110374301-110521963 46 8.63E-02 7.69E-02
SKAT chr05:156830995-156936446 71 3.18E-03 4.57E-01
chr06:025857845-025987550 57 9.32E-03 3.41E-01
chr06:135322113-135417715 58 1.34E-02 9.81E-03
chr13:109599195-109758700 18 2.31E-02 2.52E-01
chr10:104579177-104619322 6 4.65E-02 1.85E-01
NOTE: Region is in chromosome:start-stop format, where the posi-
tions are based on the reference human genome (NCBI Genome Build
36, 2006).
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Table 3.13: Top Five Targeted Regions for the T1, T5, MB, and SKAT Tests of the Global
Null Hypothesis in the CHARGE-TSS ARIC Sample
Test Region MAC p-value
T1 chr05:156830995-156936446 60 1.03E-03
chr11:046720500-046832766 43 2.74E-02
chr12:101312706-101455233 7 4.51E-02
chr12:111338491-111436622 8 4.70E-02
chr07:115925580-115935931 5 4.85E-02
T5 chr05:156830995-156936446 104 1.05E-02
chr11:046720500-046832766 43 2.74E-02
chr11:016764687-016993639 155 3.30E-02
chr11:046695000-046720000 53 4.15E-02
chr12:101312706-101455233 7 4.51E-02
MB chr05:156830995-156936446 104 2.15E-03
chr11:016764687-016993639 155 1.54E-02
chr10:070698661-070832743 41 3.68E-02
chr07:115925580-115935931 5 4.83E-02
chr12:111338491-111436622 8 4.85E-02
SKAT chr06:135322113-135417715 85 3.57E-03
chr12:111338491-111436622 8 4.21E-03
chr13:109599195-109758700 102 2.07E-02
chr07:115925580-115935931 5 2.52E-02
chr11:046695000-046720000 53 3.03E-02
NOTE: Region is in chromosome:start-stop format,
where the positions are based on the reference human
genome (NCBI Genome Build 36, 2006).
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Table 3.14: Sample Size Summary of the NHLBI ESP EA Data
With nonmissing LDL
LDL BP DPR MI Stroke Nonsequenced
ARIC 172 93 84 136 6 9553
CARDIA 14 66 32 0 0 1530
CHS 15 3 77 43 1 1186
FHS 12 52 34 147 15 2245
MESA 60 19 159 0 7 1310
WHI 46 8 286 156 49 5115
Total 319 241 672 482 78 20939
meta-analysis of the four studies using software MASS (Tang and Lin 2013).
We restricted the single-variant analysis to SNPs with MACs ≥ 5 and ended up with
109,607 SNPs. We chose the additive model and used score statistics to ensure numerical
accuracy for SNPs with low MACs. Figure 3.2 shows the quantile-quantile plots using the
MLE and LS methods in the TDS study only and in all four studies. Although the trends in
the quantile-quantile plots of the TDS study appear to be similar between the MLE and LS
methods, the MLE method clearly produces more signiﬁcant results than the LS method in
the meta-analysis. Table 3.15 lists the top 10 SNPs for the MLE method in the meta-analysis.
For the MLE method, the top SNP (chr19:45397229) in the meta-analysis is also the top
SNP in the TDS study, with the p-value in the meta-analysis being much more signiﬁcant
(2.08× 10−10 vs. 2.64× 10−7). For the LS method, although the top SNP remains the same,
its p-value in the meta-analysis is less signiﬁcant than that in the TDS study (1.17 × 10−6
vs. 4.29× 10−7).
The forest plots shown in Figure 3.3 help to explain the results in Figure 3.2 and Ta-
ble 3.15. The MLE estimates in the TDS study are very similar to the estimates in the DPR,
MI, and stroke studies. (The estimates in the stroke study tend to have large standard errors
due to its small sample size.) Thus, the MLE estimates from the meta-analysis are similar to
the MLE estimates in the TDS study but with smaller standard errors. Because of its bias,
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Figure 3.2: Quantile-quantile plots for the single-variant analysis of the LDL data using the
MLE and LS methods in the TDS study only and in all four studies included in the NHLBI
ESP EA sample. The values of the genomic control λ, deﬁned as the ratio between the
observed median of the test statistics and the median of the χ21 distribution, are also shown.
the LS method yields larger eﬀect estimates as well as (proportionately) larger standard
errors than the MLE method in the TDS study, such that the two methods have similar
standardized test statistics in the TDS study. Because the LS estimates in the TDS study
are much larger than the LS estimates in the other three studies, meta-analysis of the LS
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Table 3.15: Top 10 SNPs in the Single-Variant Analysis of the LDL Data in the NHLBI ESP
EA Sample
MLE LS
Variant ID Gene MAC All studies TDS study All studies TDS study
chr19:045397229 TOMM40 132 2.08E-10 2.64E-07 1.17E-06 4.29E-07
chr01:109814880 CELSR2 538 6.48E-08 8.57E-05 3.51E-06 9.42E-05
chr12:101685691 UTP20 546 2.06E-07 2.45E-04 6.08E-06 2.10E-04
chr12:101685852 UTP20 548 4.85E-07 5.25E-04 7.53E-06 4.61E-04
chr12:101693534 UTP20 614 9.28E-07 1.62E-03 3.35E-06 1.44E-03
chr12:101776996 UTP20 554 1.09E-06 6.76E-04 1.85E-05 6.15E-04
chr19:002039746 MKNK2 9 2.66E-06 1.91E-06 1.20E-02 9.17E-06
chr07:121513561 PTPRZ1 492 1.57E-05 3.89E-03 5.87E-05 3.84E-03
chr01:186089112 HMCN1 916 1.73E-05 1.08E-04 4.28E-03 1.14E-04
chr12:101705477 UTP20 560 1.83E-05 3.67E-03 1.05E-04 3.55E-03
NOTE: Variant ID is in chromosome:position format, where the positions are based
on the human reference sequence (UCSC Genome Browser, hg19).
estimates from the four studies yields less signiﬁcant results than the MLE meta-analysis.
We also performed single-variant analysis in the TDS study using the univariate approach
of Lin et al. (2013). Figure 3.4 compares the p-values for the multivariate and univariate
methods. The two methods yield similar results for most SNPs. This is because the correla-
tion between LDL and BP among individuals in the TDS study is only 0.01. Note that the
multivariate approach produces a more signiﬁcant p-value for the top SNP (chr19:45397229)
than the univariate approach does (2.64× 10−7 vs. 1.24× 10−5).
In gene-level analysis for rare variants, we considered variants that are nonsynonymous,
stop-gain, stop-loss, or splicing mutations. Other steps were the same as in the analysis of the
CHARGE-TSS ARIC data. The results are displayed in Figures 3.53.8 and in Tables 3.16
3.19. The conclusions regarding the performance of the MLE and LS methods are similar to
those of the single-variant analysis. Again, the MLE method yields more signiﬁcant results
than the LS method. We also performed gene-level tests of the global null hypothesis. The
results are displayed in Figure 3.9 and in Tables 3.203.22. The strongest signals appear in
the T1 tests.
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Figure 3.3: Forest plots based on the MLE and LS methods for the third, sixth, and ninth
most signiﬁcant SNPs in the analysis of the LDL data in the NHLBI ESP EA sample. Est,
SE, and CI stand for the genetic eﬀect estimate, standard error, and conﬁdence interval,
respectively.
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Figure 3.4: Plot of the p-values for the multivariate versus univariate methods in the analysis
of the LDL data in the TDS study in the NHLBI ESP EA sample. SNPs with MACs ≥ 5
are included.
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Figure 3.5: Quantile-quantile plots for the T1 tests based on the MLE and LS methods in
the analysis of the LDL data in the TDS study only and in all four studies included in the
NHLBI ESP EA sample. The values of the genomic control λ are also shown.
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Figure 3.6: Quantile-quantile plots for the T5 tests based on the MLE and LS methods in
the analysis of the LDL data in the TDS study only and in all four studies included in the
NHLBI ESP EA sample. The values of the genomic control λ are also shown.
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Figure 3.7: Quantile-quantile plots for the MB tests based on the MLE and LS methods in
the analysis of the LDL data in the TDS study only and in all four studies included in the
NHLBI ESP EA sample. The values of the genomic control λ are also shown.
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Figure 3.8: Quantile-quantile plots for the SKAT tests based on the MLE and LS methods
in the analysis of the LDL data in the TDS study only and in all four studies included in
the NHLBI ESP EA sample.
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Figure 3.9: Quantile-quantile plots for the T1, T5, and SKAT tests of the global null hy-
pothesis in the NHLBI ESP EA sample. The values of the genomic control λ are also shown
for the T1 and T5 tests.
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Table 3.16: Top 10 Genes for the T1 Tests in the Analysis of the LDL Data Using the MLE
Method in the NHLBI ESP EA Sample
MLE LS
Gene MAC ALL studies TDS study ALL studies TDS study
LDLR 70 6.90E-07 2.12E-05 1.38E-04 2.39E-05
AZIN1 42 7.71E-05 1.96E-04 1.43E-02 2.12E-04
ACTL6A 54 1.52E-04 4.31E-03 1.74E-03 7.03E-03
PPP1R15A 59 2.20E-04 2.55E-03 4.53E-03 3.64E-03
ZFP91 14 2.46E-04 5.10E-04 5.06E-03 7.96E-04
MAGEB10 15 4.64E-04 2.30E-01 3.76E-05 2.28E-01
JAKMIP2 15 4.94E-04 5.07E-02 1.67E-03 6.11E-02
C14orf21 39 7.22E-04 4.64E-03 1.16E-02 5.69E-03
NCOA3 43 9.19E-04 2.29E-03 3.24E-02 3.01E-03
PHC2 28 1.06E-03 1.00E-01 1.37E-03 1.25E-01
3.6 Discussion
Multivariate TDS is a useful and cost-eﬀective design when investigators are interested
in multiple quantitative traits but cannot aﬀord to sequence all cohort members. The
CHARGE-TSS and NHLBI ESP are two recent examples of this design. It is not hard
to envision that many large-scale whole-exome and whole-genome sequencing projects will
adopt similar multivariate TDS designs. As demonstrated in the simulation studies and in
the two real examples, standard linear regression without regard to the sampling design can
result in estimation bias, type I error inﬂation, and power loss, and the existing methods for
univariate TDS have important limitations.
In this paper, we propose for the ﬁrst time a valid and eﬃcient likelihood-based approach
to making inferences under multivariate TDS, paying special attention to gene-level tests
for rare variants. The methodology is very general and can be applied to both genetic and
non-genetic studies. The proposed EM algorithm is stable and the software is available on
our website.
Our approach is scalable to whole-exome and whole-genome sequencing studies. In our
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Table 3.17: Top 10 Genes for the T5 Tests in the Analysis of the LDL Data Using the MLE
Method in the NHLBI ESP EA Sample
MLE LS
Gene MAC ALL studies TDS study ALL studies TDS study
LDLR 70 6.90E-07 2.12E-05 1.38E-04 2.39E-05
AZIN1 42 7.71E-05 1.96E-04 1.43E-02 2.12E-04
ACTL6A 54 1.52E-04 4.31E-03 1.74E-03 7.03E-03
PPP1R15A 59 2.20E-04 2.55E-03 4.53E-03 3.64E-03
MAGEB10 17 4.05E-04 6.24E-01 2.22E-05 6.06E-01
IGSF1 117 4.21E-04 2.13E-02 3.18E-04 2.20E-02
JAKMIP2 15 4.94E-04 5.07E-02 1.67E-03 6.11E-02
C14orf21 41 5.42E-04 4.64E-03 8.33E-03 5.69E-03
TCF20 95 7.41E-04 5.62E-03 1.37E-02 5.90E-03
MACC1 143 7.54E-04 5.03E-03 1.07E-02 4.76E-03
Table 3.18: Top 10 Genes for the MB Tests in the Analysis of the LDL Data Using the MLE
Method in the NHLBI ESP EA Sample
MLE LS
Gene MAC ALL studies TDS study ALL studies TDS studies
LDLR 70 1.19E-07 4.44E-06 1.59E-05 6.44E-06
SERPINB6 13 1.86E-04 4.43E-02 5.40E-04 7.81E-02
OSBPL11 11 2.41E-04 8.56E-04 1.45E-02 2.18E-03
ZFP91 123 2.51E-04 5.26E-04 6.39E-03 8.25E-04
EFEMP2 23 3.08E-04 8.67E-02 1.95E-04 8.92E-02
NLRC5 390 5.23E-04 1.11E-02 4.06E-03 1.52E-02
COBLL1 216 7.05E-04 1.88E-02 4.12E-03 2.72E-02
DSCC1 31 7.13E-04 8.94E-02 3.20E-04 1.08E-01
JAKMIP2 15 7.64E-04 5.07E-02 2.05E-03 6.11E-02
USP54 121 9.36E-04 1.07E-02 5.03E-03 1.09E-02
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Table 3.19: Top 10 Genes for the SKAT Tests in the Analysis of the LDL Data Using the
MLE Method in the NHLBI ESP EA Sample
MLE LS
Gene MAC ALL studies TDS study ALL studies TDS study
IL8 5 1.55E-06 1.92E-01 2.01E-08 2.16E-01
ECH1 6 3.72E-05 6.32E-04 5.09E-03 2.75E-03
MAGEB10 17 4.14E-05 2.42E-01 4.30E-05 2.29E-01
EGR1 12 7.00E-05  7.00E-05 
PPP1R15A 59 7.42E-05 1.76E-04 8.23E-03 3.74E-04
CEP128 354 1.33E-04 8.76E-01 9.07E-05 8.66E-01
GRB14 100 3.09E-04 2.66E-02 6.60E-04 2.49E-02
GNA14 27 3.96E-04 9.00E-02 5.30E-04 1.03E-01
ACTL6A 54 4.60E-04 1.59E-03 1.79E-02 2.80E-03
MVK 17 5.10E-04 1.47E-04 3.28E-01 3.00E-04
Table 3.20: Top 10 Genes for the T1 Tests of the Global Null Hypothesis in the NHLBI ESP
EA Sample
Gene MAC p-value
CCDC62 7 1.96E-05
CXCR5 5 2.10E-05
PLCG1 10 4.69E-05
LDLR 31 1.04E-04
EPHX1 13 2.39E-04
CHAF1A 12 3.83E-04
SFXN5 8 5.33E-04
AZIN1 15 7.03E-04
IGSF11 7 8.28E-04
PCK1 15 1.05E-03
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Table 3.21: Top 10 Genes for the T5 Tests of the Global Null Hypothesis in the NHLBI ESP
EA Sample
Gene MAC p-value
PLCG1 10 4.69E-05
LDLR 31 1.04E-04
AQP8 66 1.36E-04
EPHX1 13 2.39E-04
PHKB 66 2.83E-04
RETSAT 74 3.77E-04
SFXN5 8 5.33E-04
AZIN1 15 7.03E-04
IGSF11 7 8.28E-04
NSMAF 23 9.53E-04
Table 3.22: Top 10 Genes for the SKAT Tests of the Global Null Hypothesis in the NHLBI
ESP EA Sample
Gene MAC p-value
RPP38 61 4.16E-04
PPP1R15A 21 5.80E-04
CKM 37 7.44E-04
C22orf31 37 7.83E-04
REV3L 103 8.25E-04
MRPS6 21 8.66E-04
MVK 6 1.08E-03
SPG7 29 1.10E-03
ARNTL2 119 1.29E-03
C7orf58 26 1.62E-03
52
single-variant analysis of the NHLBI ESP EA data, it took ∼5 seconds on an IBM HS21
machine to perform one association analysis. The computation time increases as the number
of traits or the percentage of missing data increases. When there are no covariates or
covariates are categorical (i.e. when m is small), the computation is fast. When there are
continuous covariates, we recommend splitting the genome and using multiple CPUs.
As shown in the simulation studies, the MLE method has appreciable bias and inﬂated
type I error when the normality assumption on  is severely violated. In practice, one
should inspect the trait distributions and explore parametric transformations, such as the log
transformation, or the rank-based inverse normal transformation. In genome-wide studies, a
well-behaved quantile-quantile plot for the association tests would imply that non-normality
has no undue inﬂuence on the type I error.
For single-variant analysis, we compared the MLE method with the univariate LS method.
It is also possible to consider the multivariate LS method. If one is only interested in the
marginal genetic eﬀects on each trait and the traits are completely observed for all sequenced
individuals, then univariate and multivariate LS methods yield the same results. If there is
a small proportion of missingness, then the two methods should still yield similar results. If
one is interested in the joint genetic eﬀects on multiple traits, then a multivariate model is
necessary. We adopt a multivariate model in our MLE approach primarily because the sam-
pling scheme involves multiple traits. Our model is more elaborate than a univariate model,
but it is the only approach that provides valid and eﬃcient inferences for the multivariate
TDS design.
In both the simulation studies and the real examples, all traits in the model are used in
the sampling process. In practice, investigators may be interested in secondary quantitative
traits which are not directly used for sampling but are correlated with the primary traits.
(Note that standard linear regression is valid only when a secondary trait is independent of
all primary traits, which is an unlikely scenario.) It is straightforward to analyze secondary
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traits with our MLE method. Using a multivariate normal distribution for the primary and
secondary traits, one can include each secondary trait of interest as an additional primary"
trait and use our MLE method with these (K + 1) traits.
Our approach does not require Z for nonsequenced individuals. In the NHLBI ESP,
part of Z (sequencing centers/targets) is not available for nonsequencd individuals. In
the CHARGE-TSS, Z is available for all individuals. Incorporating Z of nonsequenced
individuals into the analysis has two advantages. First, it allows the selection of individuals
for sequencing to depend on Z. Second, it improves the eﬃciency of estimation. Then the
likelihood involves the conditional distribution of G given Z(1), which is the part of Z that
is correlated with G. We plan to incorporate kernel smoothing into the likelihood to handle
continuous components in Z(1). Table 3.23 shows the estimated distribution of (Z,G) in
the analysis of the second most signiﬁcant SNP in the NHLBI ESP EA sample; there is no
strong evidence of correlation between Z and G. A similar issue arises when some part of
Z is subject to missingness. We denote that part of Z and G as G˜ and denote the rest of
Z as Z˜. We plan to formulate the conditional distribution of G˜ given Z˜ through general
odds ratio functions (Hu et al. 2010).
We have focused on the inference procedures rather than the design aspects. Although
our simulation studies indicate that the two-tail design can be more eﬃcient than the one-
tail design, the optimal design remains unknown. It is unclear what the best sampling
strategy is when multiple quantitative traits are of equal interest. Because our likelihood
framework applies to any multivariate TDS, our variance formulas can be used to compare
the eﬃciencies of diﬀerent designs.
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Table 3.23: Estimation of f(Z), f(Z,G), and f(G|Z) in the Analysis of the Second Most
Signiﬁcant SNP of the LDL data in the NHLBI ESP EA Sample
Z f̂(Z,G) f̂(G|Z)
Center Target f̂(Z) G = 0 G = 1 G = 2 G = 0 G = 1 G = 2
ARIC broad_ESP_new 0.165 0.122 0.040 0.003 0.741 0.241 0.019
ARIC uwrefseq_2009 0.317 0.204 0.104 0.009 0.645 0.327 0.029
CARDIA broad_ESP_new 0.118 0.079 0.039 0.000 0.671 0.329 0.000
CARDIA V2refseq2010 0.024 0.015 0.009 0.000 0.636 0.364 0.000
CHS broad_ESP_new 0.005 0.005 0.000 0.000 1.000 0.000 0.000
CHS uwrefseq_2009 0.027 0.019 0.008 0.000 0.693 0.307 0.000
FHS broad_ESP_new 0.097 0.075 0.018 0.003 0.778 0.189 0.033
FHS uwrefseq_2009 0.022 0.019 0.002 0.002 0.853 0.079 0.068
MESA broad_ESP_new 0.032 0.017 0.015 0.000 0.523 0.477 0.000
MESA V2refseq2010 0.097 0.068 0.027 0.002 0.702 0.282 0.016
WHI broad_ESP_new 0.013 0.010 0.003 0.000 0.751 0.249 0.000
WHI V2refseq2010 0.084 0.061 0.018 0.005 0.734 0.211 0.055
3.7 Theoretical Details
3.7.1 Derivation of the Observed-Data Likelihood
Let Vi ≡ (Vi1, . . . , ViK)T be a K×1 vector of ones and zeros indicating which components
of Yi are observed or missing for the ith individual. Let Ri indicate, by the values 1 versus
0, whether the ith individual is selected for sequencing. We make the following assumptions:
Assumption 3.1. The conditional distribution of Vi given (Yi,Zi,Gi) is a function of
(Y obsi ,Zi,Gi) for sequenced individuals and a function of Y
obs
i for nonsequenced individuals.
Assumption 3.2. The distribution of R ≡ (R1, . . . , RN) depends on (V ,Y ,Z,G) ≡
{(V1,Y1,Z1,G1), . . . , (VN ,YN ,ZN ,GN)} only through V ◦ Y ≡ (V1 ◦ Y1, . . . ,VN ◦ YN),
where ◦ denotes component-wise product.
Assumption 3.3. f(R|V ◦ Y )∏ni=1 f(Vi|Vi ◦ Yi,Zi,Gi)∏Ni=n+1 f(Vi|Vi ◦ Yi) does not
contain parameters θ and F .
Under Assumptions 3.1-3.2, the complete-data density for the underlying variables (Ri,Vi,
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Yi,Zi,Gi), i = 1, . . . , N , is
f(R,V ,Y ,Z,G)
=f(R|V ◦ Y )
N∏
i=1
f(Vi,Yi,Zi,Gi)
=f(R|V ◦ Y )
n∏
i=1
f(Vi|Vi ◦ Yi,Zi,Gi)fθ(Yi|Zi,Gi)f(Zi,Gi)
×
N∏
i=n+1
f(Vi|Vi ◦ Yi)fθ(Yi|Zi,Gi)f(Zi,Gi).
The observed data are (Ri,Vi,Vi ◦ Yi, RiZi, RiGi), i = 1, . . . , N , whose density is obtained
by integrating over the unobserved variables in the complete-data density, i.e.,
f(R,V ,V ◦ Y ,R ◦Z,R ◦G)
=f(R|V ◦ Y )
n∏
i=1
f(Vi|Vi ◦ Yi,Zi,Gi)
{ˆ
Y mis
fθ(Yi|Zi,Gi)dY mis
}
f(Zi,Gi)
×
N∏
i=n+1
f(Vi|Vi ◦ Yi)
ˆ
z,g
{ˆ
Y mis
fθ(Yi|z, g)dY mis
}
dF (z, g)
=f(R|V ◦ Y )
n∏
i=1
f(Vi|Vi ◦ Yi,Zi,Gi)
N∏
i=n+1
f(Vi|Vi ◦ Yi)
×
n∏
i=1
fθ(Y
obs
i |Zi,Gi)f(Zi,Gi)
N∏
i=n+1
ˆ
z,g
fθ(Y
obs
i |z, g)dF (z, g),
where R ◦ Z = (R1Z1, . . . , RNZN), R ◦G = (R1G1, . . . , RNGN), and Y mis is the missing
part of Y . We can ignore f(R|V ◦Y )∏ni=1 f(Vi|Vi ◦Yi,Zi,Gi)∏Ni=n+1 f(Vi|Vi ◦Yi) because
of Assumption 3.3. The remaining part of the above density is exactly the observed-data
likelihood given in (3.20).
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3.7.2 Estimation
To calculate the MLEs for (3.21), we use the EM algorithm in which missing data contain
the partially missing Yi's and the missing observations on (Z,G) for individuals not selected
for sequencing. The complete-data log-likelihood function is
N∑
i=1
[
m∑
j=1
I{(Zi,Gi) = (zj, gj)} {log fθ(Yi|zj, gj) + log qj}
]
.
At the tth iteration, the M-step maximizes
N∑
i=1
m∑
j=1
ψ̂
(t)
ij
[
E{log fθ(Yi|zj, gj)|Y obsi , zj, gj; θ̂(t)}+ log qj
]
,
where E(·|Y obsi , zj, gj; θ̂(t)) is the conditional expectation given Y obsi , (Zi,Gi) = (zj, gj),
evaluated at θ̂(t), and ψ̂(t)ij is the conditional probability of I{(Zi,Gi) = (zj, gj)} = 1 given
Y obsi , (z1, g1), . . . , (zm, gm), evaluated at θ̂
(t), q̂(t)1 , . . . , q̂
(t)
m . That is,
ψ̂
(t)
ij =

I{(Zi,Gi) = (zj, gj)} i = 1, . . . , n;
f
θ̂(t)
(Y obsi |zj ,gj)q̂(t)j
m∑
l=1
f
θ̂(t)
(Y obsi |zl,gl)q̂(t)l
i = n+ 1, . . . , N.
Write Wj = (gTj , z
T
j )
T and η = (βT,γT)T. The M-step involves the following calculations:
(η̂
(t+1)
k )
T =
(
N∑
i=1
m∑
j=1
ψ̂
(t)
ij W
⊗2
j
)−1 [ N∑
i=1
m∑
j=1
ψ̂
(t)
ij E{Yki|Y obsi , zj, gj; θ̂(t)}Wj
]
, 1 ≤ k ≤ K,
Σ̂(t+1) = N−1
N∑
i=1
m∑
j=1
ψ̂
(t)
ij E
{(
Yi − η̂(t+1)Wj
)⊗2 |Y obsi , zj, gj; θ̂(t)} ,
q̂j
(t+1) = N−1
N∑
i=1
ψ̂
(t)
ij ,
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where ηk is the kth row of η, and a⊗2 = aaT. We start with initial values η̂(0) = 0, Σ̂(0)
being the sample covariance matrix based on those Yi's with complete observations, and
q̂
(0)
j = n
−1
n∑
i=1
I{(Zi,Gi) = (zj, gj)}, j = 1, . . . ,m, and iterate until convergence to obtain
the MLEs (β̂, γ̂, Σ̂, q̂1, · · · , q̂m). In the above expressions, the conditional expectations can
be evaluated by using the fact that the missing part of Yi, denoted by Y misi , given Y
obs
i
and (zj, gj), follows a normal distribution with mean βmisi gj +γ
mis
i zj + Σ
mo
i {Σooi }−1(Y obsi −
βobsi gj − γobsi zj) and variance Σmmi − Σmoi {Σooi }−1{Σmoi }T, where βmisi and βobsi are the
corresponding parts for Y misi and Y
obs
i in β, and the same partitions apply to γ to yield
γmisi and γ
obs
i and to Σ to yield Σ
mm
i ,Σ
mo
i , and Σ
oo
i .
We estimate the asymptotic covariance matrix of the MLEs by the Louis formula (Louis
1982). We use Akl to denote the (k, l)th element of any matrix A. For i = 1, . . . , N and
j = 1, . . . ,m, we calculate the derivatives of log f(Yi|zj, gj) + log qj to obtain the {K(p +
d) +K(K + 1)/2 +m} × 1 complete-data score vector
l1ij =
[
ST1ij, . . . ,S
T
Kij, T11ij, T12ij, . . . , TKKij,P
T
ij
]T
,
where Skij = WjeTk Σ̂
−1(Yi− η̂Wj), with ek being the kth canonical vector of length K, i.e.
with 1 in the kth position and 0 in all the other positions,
Tklij =− 1
2
{1 + I(k 6= l)}(Σ̂−1)kl
+
1
4
{1 + I(k 6= l)}(Yi − η̂Wj)TΣ̂−1(ekl + elk)Σ̂−1(Yi − η̂Wj), k ≤ l,
with ekl = ekeTl and Pij = (0, . . . , 0, 1/q̂j, 0, . . . , 0)
T.We also calculate the second derivatives
as a {K(p + d) + K(K + 1)/2 + m} × {K(p + d) + K(K + 1)/2 + m} matrix, which is the
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block diagonal matrix
l2ij =
 l11ij 0{K(p+d)+K(K+1)/2}×m
0m×{K(p+d)+K(K+1)/2} l22ij
 ,
where
l11ij =

∂S1ij
∂η1
· · · ∂S1ij
∂ηK
∂S1ij
∂Σ11
· · · ∂S1ij
∂ΣKK
...
...
...
...
...
...
∂SKij
∂η1
· · · ∂SKij
∂ηK
∂SKij
∂Σ11
· · · ∂SKij
∂ΣKK
∂S1ij
∂Σ11
T · · · ∂SKij
∂Σ11
T ∂T11ij
∂Σ11
· · · ∂T11ij
∂ΣKK
...
...
...
...
...
...
∂S1ij
∂ΣKK
T · · · ∂SKij
∂ΣKK
T ∂TKKij
∂Σ11
· · · ∂TKKij
∂ΣKK

,
and l22ij is a diagonal matrix with diagonal elements {0, . . . , 0,−1/q̂2j , 0, . . . , 0}. In the above
matrix,
∂Skij
∂ηl
= −WjW Tj ekTΣ̂−1el,
∂Skij
∂Σk′l′
=− 1
2
{1 + I(k′ 6= l′)}WjeTk Σ̂−1(ek′l′ + el′k′)Σ̂−1(Yi − η̂Wj),
∂Tklij
∂Σk′l′ij
=
1
4
{1 + I(k 6= l)}{1 + I(k′ 6= l′)}
{
Σ̂−1(ek′l′ + el′k′)Σ̂−1
}
kl
− 1
8
{1 + I(k 6= l)}{1 + I(k′ 6= l′)}(Yi − η̂Wj)T{
Σ̂−1(ek′l′ + el′k′)Σ̂−1(ekl + elk)Σ̂−1
}
(Yi − η̂Wj)
− 1
8
{1 + I(k 6= l)}{1 + I(k′ 6= l′)}(Yi − η̂Wj)T{
Σ̂−1(ekl + elk)Σ̂−1(ek′l′ + el′k′)Σ̂−1
}
(Yi − η̂Wj).
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We then calculate the information matrix as
Q =−
N∑
i=1
m∑
j=1
ψ̂ijE{l2ij|Y obsi , zj, gj} −
N∑
i=1
[
m∑
j=1
ψ̂ijE{l⊗21ij|Y obsi , zj, gj}
−
(
m∑
j=1
ψ̂ijE{l1ij|Y obsi , zj, gj}
)⊗2 .
To account for the constraint that
∑m
j=1 qj = 1, we deﬁne D to be the derivative matrix of
(β,γ,Σ, q1, · · · , qm) with respect to (β,γ,Σ, q1, · · · , qm−1). Then, the covariance matrix for
(β̂, γ̂, Σ̂, q̂1, · · · , q̂m−1) is estimated by Ω = F−1, where F = DTQD.
3.7.3 Asymptotic Properties
Let Θ denote the parameter space of θ, which is a bounded open set in the interior of the
domain of θ, and F denote the space of the joint distributions of (Z,G). Let θ0 ∈ Θ and
F0 ∈ F denote the true values of θ and F . We impose the following regularity conditions
and state the asymptotic results in Theorem 1.
Assumption 3.4. With probability one, Pr(R = 1, Vk = Vl = 1|V ◦ Y ,Z,G) is bounded
away from zero, for each pair of k and l ∈ {1, . . . , K}.
Assumption 3.5. For any nonzero β and γ, Pr(βG+ γZ = 0) < 1.
Assumption 3.6. The density function of F0 is positive in its support and continuously
diﬀerentiable with respect to a suitable measure.
Theorem 3.1. Under Assumptions 3.13.6, θ̂ and F̂ (·, ·) are consistent in that |θ̂− θ0|+
supz,g|F̂ (z, g)−F0(z, g)| → 0 almost surely. In addition,
√
n(θ̂−θ0) converges in distribution
to a zero-mean normal random vector whose covariance matrix attains the semiparametric
eﬃciency bound.
Proof. The observed-data likelihood given in (3.20) is similar to the likelihood given in (6)
of Lin and Zeng (2006), which pertains to haplotype rather than genotype eﬀects. In (3.20),
fθ(Y
obs|Z,G) is the density of a multivariate linear regression model with partial missingness
60
in Y , whereas in (6) of Lin and Zeng (2006), mg(Y,X;θ), which reduces to Pα,β,ξ(Y |X)
when haplotypes are replaced by genotypes, is the density of a univariate generalized linear
model with Y being always observed. If we can verify that Conditions 13 for Pα,β,ξ(Y |X)
in Lin and Zeng (2006) are satisﬁed by fθ(Y obs|Z,G), we can use Theorem 1 of Lin and
Zeng (2006) to show the consistency, asymptotic normality, and asymptotic eﬃciency of our
estimators.
Before verifying Conditions 1-3 in Lin and Zeng (2006), we need some additional notation.
Suppose that there are s distinct missing patterns in Y , each with a positive probability of
being observed. Let δt be the indicator of the tth missing pattern. Let Y obs(t) and Y mis(t)
denote the observed and missing parts of Y for the tth missing pattern, t = 1, . . . , s. Then
fθ(Y
obs|Z,G) can be rewritten as ∏st=1 {fθ(Y obs(t)|Z,G)}δt .
Condition 1 in Lin and Zeng (2006) pertains to the identiﬁability of the regression
model. Suppose that two sets of parameters θ and θ˜ yield the same likelihood value. Then∏s
t=1
{
fθ(Y
obs(t)|Z,G)}δt = ∏st=1 {fθ˜(Y obs(t)|Z,G)}δt for sequenced individuals. By As-
sumption 3.4, we can ﬁnd, for each pair of k and l ∈ {1, . . . , K}, some t0 ∈ {1, . . . , s},
such that Yk and Yl are observed in the t0th missing pattern. Setting δt0 = 1, δt = 0, and
t 6= t0, we have fθ(Y obs(t0)|Z,G) = fθ˜(Y obs(t0)|Z,G), where both sides are multivariate
normal densities. Because Yk and Yl are components of Y obs(t0), we have ηk = η˜k, ηl = η˜l,
Σkk = Σ˜kk, Σll = Σ˜ll, and Σkl = Σ˜kl. Condition 1 in Lin and Zeng (2006) is veriﬁed.
Conditions 2 and 3 in Lin and Zeng (2006) are the same if we replace haplotypes by
genotypes. Thus, it remains to show that the information operator for θ and F is continu-
ously invertible at the true parameter values. This is tantamount to showing that the score
function at any non-trivial submodel is non-zero because the information operator is the
sum of an invertible operator and a compact operator mapping the score space of (θ0, F0) to
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itself. To this end, suppose that there exists a constant vector u, such that
uT
{
s∑
t=1
δt
∂
∂θ
log fθ(Y
obs(t)|Z,G)
}
= 0. (3.22)
Let b(t) ≡ (b(t)1 , . . . , b(t)K )T = {D(V (t))ΣD(V (t))}+{V (t) ◦ (Y − ηW )}, where V (t) represents
V in the tth missing pattern, D(V (t)) represents the diagonal matrix with the diagonal
vector being V (t), and A+ represents the Moore-Penrose generalized inverse of any square
matrix A. Then
∂
∂θ
log fθ(Y
obs(t)|Z,G) =
[
(S
(t)
1 )
T, . . . , (S
(t)
K )
T, T
(t)
11 , T
(t)
12 , . . . , T
(t)
KK
]T
,
where S(t)k = W b
(t)
k , and
T
(t)
kl =−
1
2
{1 + I(k 6= l)}[{D(V (t))ΣD(V (t))}+]kl
+
1
2
{1 + I(k 6= l)}b(t)k b(t)l , k ≤ l.
By Assumption 3.4, we can ﬁnd, for each pair of k and l ∈ {1, . . . , K}, k ≤ l, some t0 ∈
{1, . . . , s}, such that V (t0)k = V (t0)l = 1. Set δt0 = 1, δt = 0, and t 6= t0. Since Yk and Yl
can take arbitrary values and b(t0)k and b
(t0)
l are non-degenerate linear functions of Yk and Yl,
we see that b(t0)k and b
(t0)
l can take arbitrary values. By examining the linear and quadratic
terms of b(t0)k and b
(t0)
l in equation (3.22), we conclude that their corresponding coeﬃcients
must be zero. That is, uTkW = 0, u
T
l W = 0, and ukl = 0, where uk, ul, and ukl are
the components of u associated with S(t)k , S
(t)
l , and T
(t)
kl , respectively. By Assumption 3.5,
uk = 0 and ul = 0. It follows that u = 0. Thus, the score function is non-zero at any
non-trivial submodel, and Conditions 2 and 3 in Lin and Zeng (2006) hold.
Remark. Assumption 3.4 suggests that we need to observe with positive probability each
pair of components of Y in some individuals selected for sequencing in order for the MLE
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method to be applicable. We do not require a fully-observed Y for any individual. On the
other hand, both the CHARGE-TSS ARIC data and NHLBI ESP EA data contain a large
proportion of sequenced individuals with fully-observed Y . Thus, Condition 1 is not an issue
but mainly serves theoretical purposes.
3.7.4 Association Tests
For Wald tests employed in single-variant analysis, we estimate all parameters under the
alternative hypothesis. Suppose that we decompose β into (βTa ,β
T
b )
T and wish to test the
null hypothesis Ha0 : βa = 0. The Wald test statistic is Ta ≡ β̂Ta Ω−1aa β̂a, where β̂a is the MLE
of βa, and Ωaa is the covariance matrix of β̂a, which is the submatrix of Ω corresponding to
βa. We refer Ta to the χ2da distribution, with the degree of freedom da being the dimension
of βa. In particular, to test the genetic eﬀect on each trait, we consider the null hypothesis
H
(k)
0 : βk = 0 for k = 1, . . . , K. The test statistic is Tk ≡ β̂2k/Ωkk, where Ωkk is the variance
estimate of β̂k. We refer Tk to the χ21 distribution.
Gene-level tests for rare variants rely on score statistics. To test the global null hypothesis
that there is no genetic eﬀect on any trait, i.e. H0 : β = 0, we calculate the restricted MLE
of (γ,Σ, q1, · · · , qm−1) under H0. This is accomplished through the above EM algorithm
in which β is set to 0 and only (γ,Σ, q1, · · · , qm−1) is estimated. The score statistic for
testing H0 : β = 0 is U1 ≡
N∑
i=1
m∑
j=1
ψ̂ijl
(1)
1ij, where l
(1)
1ij is the subvector of l1ij corresponding to
β. It can be shown that U1 is asymptotically normal with mean 0 and covariance matrix
V1 = F11 − F12F−122 F21, where
F11 F12
F21 F22
 is the partition of F with respect to β and the
other parameters.
For T1 and T5 tests, G is the total number of mutations among variants whose MAFs are
below 1% and 5%, respectively. For the MB test, G is the weighted sum of mutations with
weights deﬁned as {MAF(1−MAF)}−1/2 for each variant (Madsen and Browning 2009). For
the above three tests, G is a scalar, and d = 1. The test statistic for testing H0 : β = 0 is
63
T(1) ≡ UT1 V −11 U1. We refer T(1) to the χ2K distribution.
For SKAT, G is a vector of the genotypes of individual variants within a gene. A SKAT-
type statistic can be deﬁned as Q2 ≡ UT1 BU1, where B is a diagonal matrix of weights that
depend on the MAFs through a beta function. The null distribution of Q2 is approximated
by
∑Kd
j=1 λjχ
2
1,j, where (λ1, . . . , λKd) are the eigenvalues of V
1/2
1 BV
1/2
1 , and (χ
2
1,1, . . . , χ
2
1,Kd)
are independent χ21 random variables (Wu et al. 2011).
To test the genetic eﬀect on a particular trait, say, the k0th trait, i.e. H0 : βk0 = 0,
where βk0 is the k0th row of β reﬂecting the genetic eﬀect on the k0th trait, we estimate
({ηk}k=1,...,K,k 6=k0 ,γk0 ,Σ, q1, · · · , qm−1) under H0. This is accomplished through the above
EM algorithm (with a modiﬁed M-step) in which βk0 is set to 0 and only ({ηk}k=1,...,K,k 6=k0 ,
γk0 ,Σ, q1, · · · , qm−1) is estimated. The M-step for estimating η is
[
η̂
(t+1)
1 , . . . , γ̂
(t+1)
k0
, . . . , η̂
(t+1)
K
]T
=
[
AT
{(
Σ̂(t)
)−1
⊗
(
N∑
i=1
m∑
j=1
ψ̂
(t)
ij W
⊗2
j
)}
A
]−1
AT
[
N∑
i=1
m∑
j=1
ψ̂
(t)
ij
{(
Σ̂(t)
)−1
⊗Wj
}
E{Yi|Y obsi , zj, gj; θ̂(t)}
]
,
where A is a pK × (pK − 1) matrix constructed by deleting the {p(k0 − 1) + 1}th column
of the pK × pK identity matrix IpK , and A⊗B denotes the Kronecker product of matrices
A and B. The score statistic for testing H0 : βk0 = 0 is U2 ≡
N∑
i=1
m∑
j=1
ψ̂ijl
(21)
1ij , wherel(21)1ij
l
(22)
1ij
 and
F (2)11 F (2)12
F
(2)
21 F
(2)
22
 are the partitions of l1ij and F with respect to βk0 and the other
parameters. It can be shown that U2 is asymptotically normal with mean 0 and covariance
matrix V2 ≡ F (2)11 − F (2)12
(
F
(2)
22
)−1
F
(2)
21 . All tests of H0 : βk0 = 0 can be constructed in a
similar manner. For SKAT tests, we use the vector of genotypes of individual variants as
the genetic variables for the k0th trait and use the burden scores for other traits to ensure
numerical stability.
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CHAPTER 4: EFFICIENT SEMIPARAMETRIC INFERENCE UNDER
TWO-PHASE, OUTCOME-DEPENDENT SAMPLING
4.1 Introduction
In epidemiological studies, the outcomes of interest (e.g, anthropometry measurements,
lipids levels, or disease status) and demographical and environmental variables (e.g., age,
gender, and smoking status) are typically available for all subjects. However, the covariates
of main interest often involve genotyping, biomarker assay, or medical imaging and thus are
prohibitively expensive to measure for all subjects, especially in a large study. If disease
status or another discrete outcome is of primary interest, then the case-control design with
an equal number of cases and controls is the most eﬃcient one (Scott and Wild 1997). If a
continuous outcome such as height is of primary interest, then a cost-eﬀective strategy is the
extreme-tail sampling design, whereby one selectively measures the expensive covariates
only for subjects with extreme values of the primary outcome measure (Lin et al. 2013). In
either case, the eﬃciency of the design can be improved by stratifying on the inexpensive
covariates.
The case-control and extreme-tail sampling designs can be viewed as special cases of the
two-phase, outcome-dependent design, which was ﬁrst introduced by White (1982). In the
ﬁrst phase of this design, the outcome of interest and inexpensive covariates are observed for
all study subjects; the information collected during the ﬁrst phase is then used to determine
which subjects to include for measurements on expensive covariates during the second phase.
This design greatly reduces the cost and other practical burdens associated with the collection
of expensive covariate data and thus has been widely used in large epidemiological studies.
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One recent example of the two-phase design is the National Heart, Lung, and Blood
Institute (NHLBI) Exome Sequencing Project (ESP), where 4494 subjects from seven cohorts
were selected for whole-exome sequencing (Lin et al. 2013). Among these subjects, 659, 806,
and 657 were selected because of extremely high or low values of body mass index (BMI),
blood pressure (BP) adjusted for age, gender, race, BMI, and anti-hypertensive medication,
and low-density lipoprotein (LDL) adjusted for age, gender, race, and lipid medication,
respectively.
Several methods have been developed for regression analysis of two-phase studies. Semi-
parametric methods, which specify a parametric form for the regression model but allow
for an arbitrary covariate distribution, are particularly appealing. In particular, Robins
et al. (1995) proposed a semiparametric estimator based on inverse probability of inclusion
weighting. Their approach requires every study subject to have a positive probability of
being selected in the second phase and thus cannot be applied to the extreme-tail design
adopted by the NHLBI ESP. In addition, their estimator can be diﬃcult to implement in
practice because it involves numerical solution of an inﬁnite-dimensional integral equation
when the outcome of interest is continuous. Lawless et al. (1999) suggested to discretize the
continuous ﬁrst-phase data into a small number of strata and then use the stratum member-
ship to select subjects in the second phase. For subjects not selected in the second phase,
only the stratum membership is used in the inference. Breslow et al. (2003) established
the asymptotic properties of the corresponding maximum likelihood estimator (MLE). Such
data discretization entails a substantial loss of information and may even bias parameter
estimation.
To improve eﬃciency, Chatterjee et al. (2003) proposed a pseudo-score estimator (PSE),
and Weaver and Zhou (2005) proposed a maximum estimated likelihood estimator (MELE).
Both methods allow the outcome of interest to be continuous but require the inexpensive
covariates to be discrete. Chatterjee and Chen (2007) extended the PSE method to allow
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for continuous inexpensive covariates in the regression analysis by using kernel smoothing
but required the second-phase selection to depend on only discrete covariates. Both the
PSE and MELE methods are statistically ineﬃcient. Song et al. (2009) and Lin et al.
(2013) considered eﬃcient estimation for two-phase studies without inexpensive covariates.
When the inexpensive covariates are available, however, this approach is ineﬃcient because
it disregards the inexpensive covariates for subjects not selected in the second phase. More
important, this approach may yield biased estimators if the second-phase selection depends
on the inexpensive covariates.
In this paper, we study eﬃcient semiparametric estimation for regression models under
general two-phase designs such that the sampling in the second phase can depend on the ﬁrst-
phase data in any manner. We allow the outcome variable to be discrete or continuous, and
we accommodate inexpensive covariates. Eﬃcient estimation under such general designs has
not been pursued previously. We stress the importance of using inexpensive covariates, which
are available in virtually all epidemiological studies, to improve the eﬃciency of the second-
phase sampling, control for confounding, and evaluate interactions among the expensive and
inexpensive covariates. We allow inexpensive covariates to be continuous and correlated
with expensive covariates, and we do not parametrize the distribution of covariates. Dealing
with this general situation is very challenging because the likelihood function involves the
conditional density functions of expensive covariates given continuous inexpensive covariates.
We overcome this diﬃculty by incorporating sieve approximations (Grenander 1981) of the
conditional density functions into the nonparametric likelihood function. We develop a
computationally eﬃcient and numerically stable expectation-maximization (EM) algorithm
to maximize the sieve likelihood. We establish the consistency, asymptotic normality, and
asymptotic eﬃciency of the resulting estimators through a novel combination of modern
empirical process theory and sieve approximation theory. We demonstrate the superiority of
the proposed methods over the existing ones through extensive simulation studies. Finally,
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we provide applications to the aforementioned NHLBI ESP.
4.2 Methods
4.2.1 Sieve Maximum Likelihood Estimation
Let Y denote the outcome of interest, X denote the vector of expensive covariates that
is measured on a fraction of subjects in the study, Z denote the vector of inexpensive co-
variates that is potentially correlated with X, and W denote the vector of inexpensive
covariates that is known to be independent of X given Z. The data (Y,X,Z,W ) are as-
sumed to be generated from the joint distribution Pθ(Y |X,Z,W )P (X|Z)P (Z,W ), where
Pθ(Y |X,Z,W ) is a parametric regression model indexed by parameter θ, P (X|Z) is the
conditional distribution of X given Z, and P (Z,W ) is the joint distribution of Z andW .
For linear regression,
Pθ(Y |X,Z,W ) = 1√
2piσ2
exp
{
−(Y − α− β
TX − γTZ − ηTW )2
2σ2
}
,
where θ = (α,βT,γT,ηT, σ2)T; for logistic regression,
Pθ(Y = 1|X,Z,W ) =
[
1 + exp
{−(α + βTX + γTZ + ηTW )}]−1 ,
where θ = (α,βT,γT,ηT)T. The linear predictors can be modiﬁed to include the interaction
terms among X, Z, and W .
Under the two-phase design, (Y , Z,W ) is measured for all n subjects in the ﬁrst phase,
and X is measured for a sub-sample of size n2 in the second phase. Let R indicate, by the
values 1 versus 0, whether the subject is selected for the measurement of X in the second
phase. We make the following assumption:
(A.1) The distribution of R depends on (Y,X,Z,W ) only through the ﬁrst-phase data
(Y,Z,W ).
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Under Assumption (A.1), the data on X are missing at random, such that the sampling
indicators (R1, . . . , Rn) can be omitted from the likelihood function when estimating θ. Thus,
the observed-data log-likelihood takes the form
n∑
i=1
Ri {logPθ(Yi|Xi,Zi,Wi) + logP (Xi|Zi)}
+
n∑
i=1
(1−Ri) log
ˆ
Pθ(Yi|x,Zi,Wi)P (x|Zi)dx. (4.23)
We maximize expression (4.23) using the nonparametric maximum likelihood estimation
(NPMLE). For each distinct observed z, we estimate P (X|z) by a discrete probability
function on the distinct observed values of X, denoted by x1, . . . ,xm (m ≤ n2). Even
with this discretization, maximization of expression (4.23) is not feasible when Z contains
continuous components because then only a small number of the observations on X are
associated with each distinct observed z.
To tackle this challenge, we approximate P (X|z) by the method of sieves (Grenander
1981). Speciﬁcally, we use the B-spline basis (Schumaker 1981) to construct the approx-
imating functions. Assuming that Z has bounded support, we center and rescale each
component of Z such that it has support on [0, 1]. We then partition the interval [0, 1]
as ∆ ≡ {t−q+1 = . . . = t−1 = 0 = t0 < t1 < . . . < tbn+1 = 1 = . . . = tq+bn}, where
{tl: l = −q + 1, . . . , q + bn} are the knots, q is the order of the B-spline basis, and bn is the
number of interior knots. The number bn is determined by the ﬁrst-phase sample size n.
For ease of implementation, we choose the interior knots as evenly spaced partitions in [0, 1]
with gap 1/(bn + 1). Let {N ql (z)}bnl=−q+1 be a one-dimensional normalized B-spline basis of
order q associated with ∆. We construct N ql (z) from the recursive formula
N ql (z) =
z − tl
tl+q−1 − tlN
q−1
l (z) +
tl+q − z
tl+q − tl+1N
q−1
l+1 (z), l = −q + 1, . . . , bn,
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where N1l (z) = I(tl ≤ z ≤ tl+1), l = 0, . . . , bn. We refer to {N1l (z)}bnl=0 as the histogram
basis. We then construct the multivariate B-spline basis on the support of Z as
{Bql (Z): Bql (Z) = N ql1(Z1) · · ·N qldz (Zdz), l = (l1, . . . , ldz)
T, l1, . . . , ldz = −q + 1, . . . , bn},
where Zv is the vth component of Z, and dz is the dimension of Z. To simplify notation, we
order the (bn + q)dz multivariate basis functions as B
q
(−q+1,...,−q+1)(Z), . . . , B
q
(bn,...,bn)
(Z) and
then re-index them with j = 1, . . . , (bn+q)dz . Because the B-spline basis functions have local
support, we approximate logP (Xi|Zi) and P (x|Zi) in expression (4.23) by
∑m
k=1 I(Xi =
xk)
∑sn
j=1B
q
j (Zi) log pkj and
∑m
k=1 I(x = xk)
∑sn
j=1B
q
j (Zi)pkj, respectively, where sn = (bn+
q)dz , and pkj = sn
´
P (xk|z)Bqj (z)dz.
We aim to maximize the following function
ln(θ, {pkj}) =
n∑
i=1
Ri
{
logPθ(Yi|Xi,Zi,Wi) +
m∑
k=1
sn∑
j=1
I(Xi = xk)B
q
j (Zi) log pkj
}
+
n∑
i=1
(1−Ri) log
{
m∑
k=1
Pθ(Yi|xk,Zi,Wi)
sn∑
j=1
Bqj (Zi)pkj
}
(4.24)
under the constraints of
∑m
k=1 pkj = 1 and pkj ≥ 0 (k = 1, . . . ,m; j = 1, . . . , sn). With the
use of the empirical distribution function of X given Z, parameter estimation based on the
maximization of expression (4.24) is feasible even when X is multidimensional.
Remark 4.1. If there are no inexpensive covariates Z and W , then the observed-data
log-likelihood (4.23) reduces to
n∑
i=1
Ri {logPθ(Yi|Xi) + logP (Xi)}+
n∑
i=1
(1−Ri) log
ˆ
Pθ(Yi|x)P (x)dx. (4.25)
Song et al. (2009) and Lin et al. (2013) maximized expression (4.25) using the NPMLE,
where P (X) is estimated by the discrete probabilities at the observed values of X. This
MLE approach, denoted by MLE0 hereafter, can be regarded as a special case of our proposed
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SMLE approach. If the inexpensive covariates are available for all subjects but the second-
phase selection does not depend on either Z orW , then the MLE0 method can be adopted
by redeﬁning the expensive covariates as (XT,ZT,W T)T and disregarding Z and W
for subjects not selected in the second phase. This data reduction approach may entail a
substantial loss of information. If the second-phase selection does depend on Z and W ,
then expression (4.25) no longer correctly reﬂects the sampling mechanism, and the MLE0
method is generally biased.
4.2.2 EM Algorithm
Direct maximization of expression (4.24) is diﬃcult due to the intractable form of the
second term. To make the problem more tractable, we artiﬁcially create a latent variable U
for subjects with R = 0 such that U takes values on 1/sn, . . . , 1 and satisﬁes the equations
P (U = j/sn|Z,W ) = Bqj (Z), P (X = xk|Z,W , U = j/sn) = P (X = xk|U = j/sn) = pkj,
and P (Y |X,Z,W , U) = P (Y |X,Z,W ). Consequently, P (X = xk|Z) =
∑sn
j=1 B
q
j (Z)pkj
for subjects with R = 0, and the second term in expression (4.24) is equivalent to the log-
likelihood of (Yi,Zi,Wi), assuming that the complete data consist of (Yi,Xi,Zi,Wi, Ui) but
with both Xi and Ui missing.
We devise an EM-type algorithm to maximize expression (4.24) by treating (X, U) for
subjects with R = 0 as missing. The complete-data log-likelihood is
n∑
i=1
Ri
{
logPθ(Yi|Xi,Zi,Wi) +
m∑
k=1
sn∑
j=1
I(Xi = xk)B
q
j (Zi) log pkj
}
+
n∑
i=1
(1−Ri)
m∑
k=1
I(Xi = xk) logPθ(Yi|xk,Zi,Wi)
+
n∑
i=1
(1−Ri)
m∑
k=1
sn∑
j=1
I(Xi = xk, Ui = j/sn) log pkj.
In the E-step, we calculate the conditional expectations of I(Xi = xk) and I(Xi = xk, Ui =
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j/sn) given the observed data for the ith subject with Ri = 0 as
q̂ik =
Pθ(Yi|xk,Zi,Wi)
∑sn
j=1B
q
j (Zi)pkj∑m
k′=1 Pθ(Yi|xk′ ,Zi,Wi)
∑sn
j=1B
q
j (Zi)pk′j
, k = 1, . . . ,m,
and
ψ̂kji =
Bqj (Zi)pkj∑sn
j=1B
q
j (Zi)pk′j
q̂ik, k = 1, . . . ,m, j = 1, . . . , sn,
respectively. In the M-step, we update θ by maximizing
n∑
i=1
Ri logPθ(Yi|Xi,Zi,Wi) +
n∑
i=1
(1−Ri)
m∑
k=1
q̂ik logPθ(Yi|xk,Zi,Wi). (4.26)
Expression (4.26) is a weighted sum of the log-likelihood functions for the regression model
Pθ(Y |X,Z,W ). Thus, we can use existing algorithms for weighted regression to maximize
expression (4.26). We update pkj (k = 1, . . . ,m; j = 1, . . . , sn) by maximizing
n∑
i=1
Ri
m∑
k=1
sn∑
j=1
I(Xi = xk)B
q
j (Zi) log pkj +
n∑
i=1
(1−Ri)
m∑
k=1
sn∑
j=1
ψ̂kji log pkj
such that
pkj =
∑n
i=1
{
RiI(Xi = xk)B
q
j (Zi) + (1−Ri)ψ̂kji
}
∑m
k=1
∑n
i=1
{
RiI(Xi = xk)B
q
j (Zi) + (1−Ri)ψ̂kji
} .
We start with initial values α̂(0) = 0, β̂(0) = 0, γ̂(0) = 0, η̂(0) = 0, σ̂2
(0)
being the sample
variance of Y (in linear regression), and p̂(0)kj =
∑n
i=1RiI(Xi = xk)B
q
j (Zi)/
∑n
i=1 Ri
Bqj (Zi), and we iterate until convergence to obtain the sieve maximum likelihood estimators
(SMLEs) θ̂ and p̂kj (k = 1, . . . ,m; j = 1, . . . , sn). Because the MLE for the distribution func-
tion of Z is the empirical distribution function based on (Z1, . . . ,Zn), the joint distribution
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function of (X,Z), denoted by F (·, ·), can be estimated by
F̂ (x, z) = n−1
m∑
k=1
n∑
i=1
I(xk ≤ x,Zi ≤ z)
sn∑
j=1
Bqj (Zi)p̂kj.
Remark 4.2. When Z is a scalar, we can use the histogram basis {B1j (z)}bn+1j=1 to estimate
P (X|Z) (see Section 4.2.3). In this case, the artiﬁcial latent variable U is not needed, and
the EM algorithm can be greatly simpliﬁed. The complete-data log-likelihood becomes
n∑
i=1
Ri
{
logPθ(Yi|Xi, Zi,Wi) +
m∑
k=1
sn∑
j=1
I(Xi = xk)B
1
j (Zi) log pkj
}
+
n∑
i=1
(1−Ri)
m∑
k=1
I(Xi = xk)
{
logPθ(Yi|xk, Zi,Wi) +
sn∑
j=1
B1j (Zi) log pkj
}
.
Consequently, in the E-step, we only need to calculate q̂ik for the ith subject with Ri = 0 as
q̂ik =
sn∑
j=1
B1j (Zi)
Pθ(Yi|xk, Zi,Wi)pkj∑m
k′=1 Pθ(Yi|xk′ , Zi,Wi)pk′j
, k = 1, . . . ,m.
In the M-step, we update θ by maximizing expression (4.26) and update pkj (k = 1, . . . ,m;
j = 1, . . . , sn) by the following simple formula
pkj =
∑n
i=1
{
RiI(Xi = xk)B
1
j (Zi) + (1−Ri)B1j (Zi)q̂ik
}∑n
i=1B
1
j (Zi)
.
4.2.3 Asymptotic Properties
Let Θ denote the parameter space of θ, which is a bounded open set in the interior of the
domain of θ, and let F denote the space of the joint distributions of (X,Z). Let θ0 ∈ Θ and
F0 ∈ F denote the true values of θ and F , respectively. We impose the following regularity
conditions:
(C.1) The set of covariates (X,Z,W ) has bounded support.
73
(C.2) If there exist two sets of parameters (θ1, F1) and (θ2, F2) such that
Pθ1(Y |X,Z,W )F1(X,Z) = Pθ2(Y |X,Z,W )F2(X,Z),
where (Y,X,Z,W ) ∈ C ≡ {(y,x, z,w): P (R = 1|y, z,w) ≥ q0}, and q0 is a positive
constant, then θ1 = θ2 and F1 = F2. In addition, if there exists a constant vector v such
that [∂ log{Pθ0(y1|x, z,w1)/Pθ0(y2|x, z,w2)}/∂θ]Tv = 0 for any (yi,x, z,wi) ∈ C, i = 1, 2,
then v = 0.
(C.3) The density function of F0 is positive in its support and q-times continuously diﬀeren-
tiable with respect to a suitable measure.
(C.4) The function E(R|X,Z) is q-times continuously diﬀerentiable with respect to X and
Z.
(C.5) As n→∞, sn →∞, and n1/2s−q/dzn → 0.
Remark 4.3. The ﬁrst part of Condition (C.2) pertains to model identiﬁability with com-
plete data. For many commonly used regression models, the set C, where P (R = 1|y, z,w) ≥
q0, does not necessarily need to cover the entire support of (Y,X,Z,W ). For example, in
linear regression, C can consist of data points with extremely large or small values of Y
only. The second part of Condition (C.2) ensures that the score functions for θ are of full
rank on C. For linear regression, this condition follows from the linear independence of the
covariates (1,XT,ZT,W T)T. Condition (C.3) pertains to the smoothness of the joint distri-
bution function of (X,Z). Condition (C.4) holds for all commonly used two-phase designs,
including the extreme-tail design adopted by the NHLBI ESP. Under Condition (C.5), the
order of the B-spline basis q should be greater than dz/2. Consequently, when dz = 1, we
can choose q = 1 and use the histogram basis {B1j (z)}bn+1j=1 to estimate P (X|Z).
We state the asymptotic results in two theorems, whose proofs are given in the Appendix.
Theorem 4.1. Under Assumption (A.1) and Conditions (C.1)(C.5), ‖θ̂−θ0‖+supx,z|F̂ (x,
z)− F0(x, z)| → 0 almost surely.
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Theorem 4.2. Under Assumption (A.1) and Conditions (C.1)(C.5), n1/2(θ̂ − θ0) con-
verges in distribution to a zero-mean normal random vector whose covariance matrix attains
the semiparametric eﬃciency bound.
The proﬁle log-likelihood function for θ is pl(θ) ≡ max{pkj} ln(θ, {pkj}). As justiﬁed at
the end of the Appendix, we can estimate the limiting covariance matrix of θ̂ by the negative
inverse of the Hessian matrix of pl(θ̂). Speciﬁcally, we obtain the value of pl(θ) by holding
θ ﬁxed in the EM algorithm and obtaining the value of ln(θ, {pkj}) at convergence. Then,
we estimate the covariance matrix of θ by the negative inverse of the matrix whose (k, l)th
element is h−2n
{
pf(θ̂ + ekhn + elhn)− pf(θ̂ + ekhn)− pf(θ̂ + elhn) + pf(θ̂)
}
,
where ek is the kth canonical vector, and hn is a constant of the order n−1/2.
4.3 Simulation Studies
We conducted extensive simulation studies to compare the performance of the SMLE
and MLE0 methods in realistic situations. In the ﬁrst set of studies, we set X = U1,
Z = rU1 + U2, and W = U3, where U1, U2, and U3 are independent Uniform(0,1) variables,
and r is a parameter controlling the correlation betweenX and Z. We generated the outcome
from the linear model: Y = 0.5X + 0.5Z + 0.5W + , where  is a standard normal random
variable independent of U1, U2, and U3. We let n = 2000 and selected 150 subjects with the
highest and 150 subjects with the lowest values of Y in the second phase. For the subjects
selected in the second phase, the data consist of (Y,X,Z,W ); for those not selected in the
second phase, the data utilized by the SMLE and MLE0 methods consist of (Y, Z,W ) and
Y , respectively. In the SMLE method, we estimated P (X|Z) using the histogram basis. We
partitioned the domain of Z using evenly-spaced quantiles and varied the number of regions
sn from 5 to 15 to assess its eﬀects on model-ﬁtting. The results with diﬀerent sn are very
similar. The maximum diﬀerence in the coverage probability of the 95% conﬁdence interval
for any parameter is only 0.5%. Therefore, we only report the results for sn = 10. We
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estimated the covariance matrix of θ̂ by the proﬁle likelihood method with step size of n−1/2.
The results of the simulation studies are summarized in Table 4.24. Both the SMLE and
MLE0 parameter estimators are virtually unbiased. The SMLE variance estimator accu-
rately reﬂects the true variation, and the corresponding conﬁdence intervals have reasonable
coverage probabilities. The SMLE estimator is much more eﬃcient than the MLE0 estima-
tor for Z and W because the SMLE method utilizes additional data on (Z,W ) for those
subjects not selected in the second phase. The SMLE estimator is also more eﬃcient than
the MLE0 estimator for X, and the eﬃciency gain increases as the correlation between X
and Z increases.
Table 4.24: Simulation Results Under the Model Y = 0.5X + 0.5Z + 0.5W +  With the
Second-Phase Sample Selection Depending Only on Y
SMLE MLE0
r Covariate Bias SE SEE CP RE Bias SE
0.0 X 0.004 0.112 0.108 0.943 1.029 0.005 0.114
Z 0.001 0.082 0.083 0.951 1.923 0.006 0.114
W −0.001 0.078 0.078 0.952 2.126 0.005 0.114
0.1 X 0.005 0.112 0.109 0.941 1.036 0.004 0.114
Z 0.004 0.081 0.082 0.951 1.973 0.006 0.114
W −0.001 0.078 0.078 0.952 2.153 0.005 0.115
0.2 X 0.005 0.112 0.109 0.945 1.077 0.004 0.116
Z 0.005 0.081 0.082 0.952 2.029 0.006 0.115
W −0.001 0.078 0.078 0.952 2.167 0.005 0.115
0.3 X 0.004 0.114 0.111 0.945 1.104 0.005 0.119
Z 0.005 0.081 0.082 0.952 2.056 0.006 0.116
W −0.001 0.078 0.078 0.953 2.189 0.005 0.115
NOTE: Bias and SE are, respectively, the empirical bias and standard
error of the parameter estimator; SEE is the empirical mean of the
standard error estimator; CP is the coverage probability of the 95%
conﬁdence interval; RE is the empirical variance of MLE0 over that of
SMLE. Each entry is based on 10,000 replicates.
In the second set of simulation studies, we generated the data from the model Y =
0.5X + 0.5Z + 0.5W + 0.4XW + . The results are summarized in Table 4.25. The SMLE
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estimator is much more eﬃcient than the MLE0 estimator for all covariates. In addition, the
relative eﬃciency of the SMLE estimator to the MLE0 estimator for X is much higher with
the interaction term than without the interaction term in the regression model.
Table 4.25: Simulation Results Under the Model Y = 0.5X + 0.5Z + 0.5W + 0.4XW + 
With the Second-Phase Sample Selection Depending Only on Y
SMLE MLE0
r Covariate Bias SE SEE CP RE Bias SE
0.0 X 0.009 0.225 0.214 0.935 1.207 0.010 0.248
Z 0.001 0.087 0.087 0.950 1.885 0.008 0.120
W 0.005 0.208 0.199 0.941 1.400 0.011 0.246
XW −0.008 0.388 0.374 0.941 1.275 0.001 0.438
0.1 X 0.012 0.224 0.213 0.934 1.244 0.011 0.250
Z 0.006 0.086 0.086 0.951 1.972 0.007 0.121
W 0.005 0.206 0.199 0.944 1.454 0.012 0.248
XW −0.009 0.385 0.372 0.940 1.321 0.000 0.443
0.2 X 0.011 0.220 0.211 0.935 1.316 0.011 0.252
Z 0.007 0.084 0.085 0.949 2.082 0.007 0.122
W 0.005 0.202 0.196 0.943 1.535 0.012 0.251
XW −0.009 0.377 0.365 0.941 1.396 0.000 0.446
0.3 X 0.009 0.218 0.209 0.938 1.387 0.011 0.256
Z 0.007 0.083 0.084 0.950 2.147 0.007 0.122
W 0.004 0.199 0.192 0.944 1.635 0.012 0.254
XW −0.008 0.369 0.358 0.942 1.494 0.000 0.451
NOTE: See the Note to Table 1.
In the above two sets of simulation studies, the second-phase selection depends on the
outcome only such that MLE0 provides unbiased estimation of all parameters. If the second-
phase selection depends on both the outcome and inexpensive covariates, then MLE0 may
be biased, whereas PSE (Chatterjee et al. 2003, Chatterjee and Chen 2007) can still be
adopted provided that the sampling depends on only discrete covariates. In a third set of
simulations, we compared the SMLE, MLE0, and PSE methods in this scenario. Speciﬁcally,
we set X = I(U1 > 0.8) and Z = I(Z˜ > z˜0.8), where Z˜ = rX + U2, r is a parameter
controlling the correlation between X and Z, U1 and U2 are independent Uniform(0,1), and
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z˜0.8 is the 80% quantile of Z˜. We generated the outcome from the model Y = X + Z + ,
where  is a standard normal random variable independent of U1 and U2. In the ﬁrst phase,
we simulated a cohort of 4000 subjects and deﬁned six strata according to the values of Z
and Y . That is, for subjects with Z = 0, we deﬁned three strata according to whether their
values of Y are less than the 5% quantile, greater than the 95% quantile, or between these
two quantiles; for subjects with Z = 1, we deﬁned another three strata according to whether
their values of Y are less than the 20% quantile, greater than the 80% quantile, or between
these two quantiles. The quantiles were chosen such that each of the extreme-tail strata
contained ∼160 subjects. In the second phase, we only included subjects with values of Y in
the four extreme-tail strata such that n2 ≈ 640. Because Z is binary, for the SMLE method
we estimated P (X|Z) by the empirical probability of X given Z. As shown in Table 4.26,
the SMLE method is much more eﬃcient than the PSE method, and the eﬃciency gain
increases as the correlation between X and Z decreases. The MLE0 parameter estimators
are severely biased whether X and Z are correlated or not.
Table 4.26: Simulation Results When the Second-Phase Sample Selection Depends on Both
Y and Z
SMLE MLE0 PSE
r Covariate Bias SE SEE CP RE Bias SE Bias SE
0.0 X 0.005 0.074 0.073 0.952 1.307 0.291 0.096 0.006 0.085
Z 0.000 0.047 0.047 0.947 1.146 −0.499 0.044 0.000 0.051
0.1 X 0.004 0.070 0.070 0.952 1.220 0.267 0.093 0.004 0.078
Z 0.000 0.049 0.049 0.945 1.123 −0.556 0.041 0.001 0.052
0.2 X 0.003 0.067 0.067 0.952 1.154 0.254 0.090 0.002 0.072
Z 0.000 0.052 0.051 0.944 1.106 −0.609 0.039 0.000 0.055
0.3 X 0.003 0.066 0.066 0.950 1.118 0.241 0.089 0.002 0.070
Z 0.000 0.056 0.055 0.945 1.092 −0.658 0.038 0.000 0.059
NOTE: Bias and SE are, respectively, the empirical bias and standard error of the pa-
rameter estimator; SEE is the empirical mean of the standard error estimator; CP is the
coverage probability of the 95% conﬁdence interval; RE is the empirical variance of PSE
over that of SMLE. Each entry is based on 10,000 replicates.
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4.4 NHLBI ESP
The NHLBI ESP was designed to identify genetic variants in all protein-coding regions of
the human genome that are associated with heart, lung, and blood diseases. It involves seven
cohorts: the Atherosclerosis Risk in Communities (ARIC) study (The ARIC Investigators
1989); Coronary Artery Risk Development in Young Adults (CARDIA) study (Friedman
et al. 1988); Cardiovascular Health Study (CHS) (Fried et al. 1991); Framingham Heart
Study (FHS) (Dawber et al. 1951); Jackson Heart Study (Taylor Jr et al. 2005); Multi-
Ethnic Study of Atherosclerosis (MESA) (Bild et al. 2002); and Women's Health Initiative
(WHI) (The Women's Health Initiative Study Group 1998). As mentioned in Section 1,
the NHLBI ESP consisted of multiple studies, some of which employed two-phase designs.
Exome sequencing was performed on the selected subjects at the University of Washington
and the Broad Institute. Details for the design, sample selection criteria, genotype quality
control, and annotation can be found in Lin et al. (2013). We provide applications to the
BP and LDL studies in the NHLBI ESP.
4.4.1 BP Study
We considered the BP study in the NHLBI ESP. The ﬁrst phase was comprised of 28,202
subjects from the ARIC, CARDIA, CHS, FHS, JHS, and MESA cohorts. In the second phase,
253 and 245 subjects from the upper and lower tails of the BP distribution, respectively, were
selected by the NHLBI ESP investigators for sequencing. The selection was not based on the
original BP values, but rather the average residuals from the linear models relating diastolic
and systolic BP values to age, gender, race, BMI, and anti-hypertensive medication. In
addition to the 498 subjects selected from the two tails of the BP distribution, the second-
phase sample also included 410 subjects from the deeply phenotyped reference (DPR) group,
which is a random sample of subjects with measurements on a common set of phenotypes.
Because the original BP values were not available for those subjects without the sequence
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data, we considered the average BP residuals as the outcome of interest in the analysis. We
included log-transformed BMI, race, age, age-squared, and cohort indicators as covariates.
Although BMI and race are not correlated with the BP residuals, they are potentially corre-
lated with single-nucleotide polymorphism (SNP) genotypes and thus may provide informa-
tion on SNP genotypes for those subjects without the sequence data. When implementing
the SMLE method, we let Z include log-transformed BMI and race andW include the other
covariates. In the sieve approximation, we used the histogram basis because Z contains only
one continuous component (i.e., log-transformed BMI). We partitioned the domain of BMI
using separate evenly-spaced quantiles for the European Americans (EAs) and African Amer-
icans (AAs). In genome-wide association studies, a well-behaved quantile-quantile (QQ) plot
and a close-to-one genomic control λ, which is deﬁned as the ratio between the observed me-
dian of the test statistics and the median of the χ21 distribution, would imply good model
ﬁtting and proper type I error control. We used the QQ plot and genomic control λ to select
the number of regions; this resulted in three regions for the EAs and one region for the AAs
(Figure 4.10).
We restricted our analysis to the 31,009 SNPs with minor allele frequencies (MAFs)
greater than 10%. We chose the additive genetic model, under which the genetic variable
codes the number of minor alleles that an subject carries at a variant site. Figure 4.11 shows
the QQ plots for the SMLE and MLE0 methods. Because the second-phase selection is
solely determined by the outcome of interest, the MLE0 method is valid. The SMLE method
produces more signiﬁcant results than the MLE0 method. Table 4.27 lists the top 10 SNPs
for the SMLE method. The genetic eﬀect estimates are similar between the two methods.
Correlations between log-transformed BMI and the SNP genotypes are weak. When the
SNP genotypes are weakly correlated with race, the standard error estimates of the SMLE
method are comparable to those of the MLE0 method; when the SNP genotypes are strongly
correlated with race, the standard error estimates of the SMLE method are much smaller
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Figure 4.10: Quantile-quantile plots for the analysis of the BP study in the NHLBI ESP
using the SMLE method with diﬀerent numbers of sieve regions.
than those of the MLE0 method. These results are consistent with the theoretical and
simulation results.
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Figure 4.11: Quantile-quantile plots for the analysis of the BP study in the NHLBI ESP
using the SMLE and MLE0 methods.
4.4.2 LDL Study
We next considered the LDL study in the NHLBI ESP. The ﬁrst phase was comprised
of 49,904 subjects from the aforementioned seven cohorts. In the second phase, 604 sub-
jects with extremely large or small values of the residuals from the linear regression of
log-transformed LDL on age, gender, race, and lipid medication and 923 subjects from the
DPR group were selected by the NHLBI ESP investigators for sequencing. We considered
82
Table 4.27: Top 10 SNPs in the Analysis of the BP Study in the NHLBI ESP
Correlation SMLE MLE0
SNP MAF log (BMI) Race Est SE p-value Est SE p-value
19:001061910 0.12 0.13 0.68 3.37E-01 6.92E-02 1.14E-06 5.06E-01 2.21E-01 2.20E-02
18:044595809 0.43 0.00 0.11 2.04E-01 4.63E-02 9.93E-06 2.05E-01 4.61E-02 8.37E-06
18:051904644 0.25 0.00 −0.27 2.29E-01 5.63E-02 4.65E-05 2.14E-01 5.64E-02 1.47E-04
08:017478527 0.14 0.08 0.40 3.18E-01 7.84E-02 4.98E-05 3.21E-01 9.10E-02 4.19E-04
20:033874784 0.11 0.10 0.64 3.33E-01 8.28E-02 5.73E-05 4.18E-01 1.47E-01 4.46E-03
18:051904641 0.25 −0.01 −0.27 2.23E-01 5.62E-02 7.13E-05 2.09E-01 5.59E-02 1.86E-04
07:101713590 0.18 0.01 −0.02 2.58E-01 6.59E-02 9.24E-05 2.17E-01 6.63E-02 1.06E-03
09:019087196 0.12 0.06 0.43 3.80E-01 9.94E-02 1.30E-04 4.22E-01 1.18E-01 3.43E-04
18:044585955 0.38 −0.08 −0.05 1.84E-01 4.81E-02 1.34E-04 1.89E-01 4.73E-02 6.54E-05
19:007166388 0.28 0.09 0.39 2.01E-01 5.39E-02 1.93E-04 1.79E-01 5.55E-02 1.29E-03
NOTE: SNP name is in the chromosome:position format, where the positions are based on the
human reference sequence (UCSC Genome Browser, hg19). Est and SE stand for the genetic eﬀect
estimate and standard error, respectively. Correlation pertains to the SNP and the covariate.
log-transformed LDL as the outcome of interest and included log-transformed BMI, race,
age, age-squared, gender, and cohort as covariates. As in Section 4.4.1, when implementing
the SMLE method, we let Z include log-transformed BMI and race andW include the other
covariates. In the sieve approximation, we used the histogram basis and partitioned the do-
main of BMI using separate evenly-spaced quantiles for the EAs and AAs. We used the QQ
plot and genomic control λ to select the number of regions; this resulted in one region for
both EAs and AAs (Figure 4.12).
We restricted our analysis to the 26,431 SNPs with MAFs greater than 15%. We chose
the additive genetic model. Figure 4.13 shows the QQ plots using the SMLE and MLE0
methods. The observed p-values of the SMLE method agree very well with the global null
hypothesis of no association, except at the extreme right tail. By contrast, the observed
p-values of the MLE0 method deviate substantially from the null distribution, reﬂecting
excessive false-positive results. This is because the second-phase selection is determined by
both the outcome of interest and the inexpensive covariates. Incidentally, the PSE method
of Chatterjee and Chen (2007) could not be applied here because it does not allow the
second-phase selection to depend on continuous covariates.
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Figure 4.12: Quantile-quantile plots for the analysis of the LDL study in the NHLBI ESP
using the SMLE method with diﬀerent numbers of sieve regions.
4.5 Discussion
We have developed eﬃcient semiparametric inference procedures for general two-phase
designs. The likelihood function of interest is not tractable because it involves the con-
ditional density function of expensive covariates given continuous inexpensive covariates.
We approximate this conditional density function by the method of sieves. We prove the
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Figure 4.13: Quantile-quantile plots for the analysis of the LDL study in the NHLBI ESP
using the SMLE and MLE0 methods.
asymptotic properties of the proposed estimators through a novel combination of modern
empirical process theory and sieve approximation theory. Our framework does not require
every study subject to have a positive selection probability in the second phase and thus cov-
ers a wide spectrum of two-phase designs. We provide easily-veriﬁable conditions on model
identiﬁability that rely only on subjects with complete data.
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The proposed EM algorithm is numerically stable and computationally eﬃcient. The M-
step only involves maximizing the log-likelihood of weighted regression, and the calculations
of q̂ik and ψ̂kji in the E-step, as well as p̂kj, have explicit formulas. If Z is a scalar, then
one can use the histogram basis, such that the algorithm becomes extremely simple. In our
analysis of the BP and LDL studies in the NHLBI ESP, it took ∼10 seconds on an IBM HS21
machine to perform one association analysis. An R package that implements the proposed
method is available on our website.
Lin et al. (2013) analyzed the LDL study in the NHLBI ESP using the MLE0 method.
To avoid the dependence of the second-phase selection on the inexpensive covariates, they
used the residuals instead of the original LDL values as the outcome of interest, even though
the LDL values were available for all subjects. This workaround is not desirable because the
resulting genetic eﬀect estimates are diﬃcult to interpret and not comparable with estimates
from studies that use the original LDL values.
In our sieve approximation to P (X|Z), the number of interior knots bn in the domain
of Z can be chosen in a data-adaptive manner. One possible approach for choosing bn is
through cross-validation. For any ﬁxed bn, we use part of the data as the test set and the
remainder as the validation set. We evaluate expression (4.24) in the validation set using
estimates obtained from the test set. The optimal number of interior knots bn is the value
that maximizes the average cross-validation likelihood. Alternative approaches can also be
used to choose bn. As demonstrated in Section 4, one can use the QQ plot and genomic
control λ to choose the appropriate bn in genetic association studies.
We have assumed that the second-phase selection depends on a single outcome. If the
selection depends on multiple outcomes in one study, then one should consider all of them
simultaneously in a multivariate regression model in order to obtain valid inference. Recently,
Tao et al. (2015) extended the MLE0 approach to multivariate outcome-dependent sampling
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without inexpensive covariates. We can extend our SMLE approach to multivariate outcome-
dependent sampling with inexpensive covariates. We simply replace Pθ(Y |X,Z,W ) in
expression (4.24) by the conditional density function Pθ(Y |X,Z,W ) of the multivariate
outcome Y given covariates. If Y contains missing components, then we need to modify
the EM algorithm in Section 2.2 by ﬁrst calculating the conditional expectations of the
missing components given the observed data in the E-step and then replacing the missing
components with their conditional expectations in the M-step. We expect Theorems 1 and
2 to continue to hold.
In both the simulation studies and NHLBI ESP applications, the outcome of interest
is always used in the second-phase sampling process. In practice, investigators may be
interested in a secondary outcome that is not used for sampling but is correlated with the
primary outcome used for sampling. In light of the above discussion on multivariate outcome-
dependent sampling, it is straightforward to analyze the secondary outcome by assuming a
bivariate regression model for the primary and secondary outcomes.
Although we have focused on the parametric regression model Pθ(Y |X,Z,W ), our ap-
proach can be extended to semiparametric regression models, particularly those with cen-
sored time-to-event outcomes. When θ contains both Euclidean and inﬁnite-dimensional
components, the maximizization of expression (4.26) in the EM algorithm is more involved,
and the proof of Theorem 1 requires modiﬁcation. Recently, Zeng and Lin (2014) considered
eﬃcient estimation of semiparametric transformation models for two-phase cohort studies
with censored data. They employed a kernel smoothing approach to approximate P (X|Z)
when Z contains continuous components. Both kernel smoothing and sieve approximation
are powerful nonparametric tools for density estimation. We adopted the sieve approxima-
tion approach because it is computationally more eﬃcient, especially when the dimension of
Z is one.
This paper is focused on the inference procedures rather than the design aspects of
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two-phase studies. An important topic of investigation is the optimal study design when
the primary interest is to estimate β. When the outcome is continuous and there is no
inexpensive covariate, Lin et al. (2013) showed that the eﬃcient information for estimating
β using the MLE0 method is approximately Var(Y |R = 1)Var(X|R = 1)/σ4 (assuming that
X is a scalar). This implies that the study design is more eﬃcient if it selects subjects
with more extreme values of Y . For general two-phase studies with (possibly multivariate)
continuous outcomes of interest, it is unclear what the best sampling strategy is. Because
our likelihood framework applies to any two-phase design, the variance estimators for the
SMLE method can be used to evaluate the eﬃciencies of diﬀerent designs.
4.6 Proofs of Theorems
Proof of Theorem 4.1. Because θ̂ is bounded and F̂ (x, z) is a distribution function with
bounded support, it follows from Helly's selection theorem that, for any subsequence of θ̂
and F̂ (x, z), there exists a further subsequence, still denoted as θ̂ and F̂ (x, z), such that θ̂
converges almost surely to some vector θ∗ and F̂ (x, z) converges weakly to some function
F ∗(x, z). Theorem 1 will hold if we can show that θ∗ = θ0 and F ∗ = F0.
Because p̂kj maximizes expression (4.24), diﬀerentiating expression (4.24) with respect
to pkj yields
n∑
i=1
Ri
I(Xi = xk)B
q
j (Zi)
pkj
+
n∑
i=1
(1−Ri)
Pθ̂(Yi|xk,Zi,Wi)Bqj (Zi)∑sn
j′=1
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)Bqj′(Zi)pk′j′
= µ̂j, (4.27)
where µ̂j is the Lagrange multiplier for the constraint that
∑m
k=1 p̂kj = 1. By multiplying
both sides of equation (4.27) with pkj and then summing over k, we have
µ̂j =
n∑
i=1
RiB
q
j (Zi) +
n∑
i=1
(1−Ri)
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)Bqj (Zi)pk′j∑sn
j′=1
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)Bqj′(Zi)pk′j′
.
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Consequently,
p̂kj =
∑n
i=1 RiI(Xi = xk)B
q
j (Zi)
µ̂j −
∑n
i=1(1−Ri)
P
θ̂
(Yi|xk,Zi,Wi)Bqj (Zi)∑sn
j′=1
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)B
q
j′ (Zi)p̂k′j′
,
and
F̂ (x, z) = n−1
m∑
k=1
n∑
i=1
I(xk ≤ x,Zi ≤ z)
sn∑
j=1
Bqj (Zi)p̂kj.
It follows that
P̂ (X = xk|z) =
sn∑
j=1
Bqj (z)p̂kj
=
sn∑
j=1
Bqj (z)
∑n
i=1RiI(Xi = xk)B
q
j (Zi)∑n
i=1
{
Ri + (1−Ri)
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)p̂k′j−Pθ̂(Yi|xk,Zi,Wi)∑sn
j′=1
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)B
q
j′ (Zi)p̂k′j′
}
Bqj (Zi)
.
Because the B-spline basis functions have local support, we have |Bqj (z˜)−Bqj (z)I(‖z˜−z‖ ≤
ξn)| . ξn for nonzero Bqj (z˜) and Bqj (z), j = 1, . . . , sn, where ξn = (bn + 1)−1, and .
means less than or equal to up to a constant. Thus, the distribution function F̂ (x, z) is
asymptotically equivalent to
n−1
m∑
k=1
n∑
i=1
I(xk ≤ x,Zi ≤ z)
∑sn
j=1
∑n
i′=1Ri′I(Xi′ = xk, ‖Zi′ −Zi‖ ≤ ξn)Bqj (Zi)
g1n(xk,Zi; θ̂, F̂ )
,
where
g1n(x, z; θ̂, F̂ ) =
sn∑
j=1
n∑
i=1
{
1− (1−Ri) Pθ̂(Yi|x,Zi,Wi)∑sn
j′=1
∑m
k′=1 Pθ̂(Yi|xk′ ,Zi,Wi)Bqj′(Zi)p̂k′j′
}
× I(‖Zi − z‖ ≤ ξn)Bqj (z).
We wish to show that (nsn)−1g1n(x, z; θ̂, F̂ ) is bounded away from zero for suﬃciently
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large n. Because
n−1
sn∑
j′=1
m∑
k=1
Pθ̂(y|xk, z,w)Bqj′(z)pkj′
=
ˆ
x˜
Pθ̂(y|x˜, z,w)F̂ (dx˜, z)→
ˆ
x˜
Pθ∗(y|x˜, z,w)F ∗(dx˜, z)
uniformly in (y, z,w), (nsn)−1g1n(x, z; θ̂, F̂ ) converges to g1(x, z;θ∗, F ∗) for (x, z) in the
support of (X,Z), where
g1(x, z;θ
∗, F ∗) = E
[{
1− (1−R)Pθ∗(Y |x,Z,W )
´
x˜
F ∗(dx˜,Z)´
x˜
Pθ∗(Y |x˜,Z,W )F ∗(dx˜,Z)
}
fz(Z)
∣∣∣∣Z = z] ≥ 0,
and fz(·) is the density function of Z. Consequently,
∑m
k=1 P̂ (X = xk|z) converges to
ˆ
E {Rfz(Z)|Z = z}
g1(x, z;θ∗, F ∗)
dx = 1.
If g1(x, z;θ∗, F ∗) is not bounded away from zero, then there exists x0 ∈ Dx, where Dx is the
support of X, such that g1(x0, z;θ∗, F ∗) = 0. Because g1(x0, z;θ∗, F ∗) is a smooth function
of the continuous components of x, there exists a positive constant δ such that for any  > 0,
1 ≥
ˆ
E {Rfz(Z)|Z = z}
g1(x, z;θ∗, F ∗) + 
dx ≥
ˆ
‖x−x0‖≤δ
E {Rfz(Z)|Z = z}
|g1(x, z;θ∗, F ∗)|+ dx
&
ˆ
‖x−x0‖≤δ
E {Rfz(Z)|Z = z}
‖x− x0‖+  dx, (4.28)
where & means greater than or equal to up to a constant. Because
´
‖x−x0‖≤δ(1/‖x−x0‖)dx
is inﬁnite, the last integration in expression (4.28) also goes to ∞ when  → 0, which is a
contradiction. Thus, g1(x0, z;θ∗, F ∗) is bounded away from zero for (x, z) in the support of
(X,Z). The same conclusion holds for (nsn)−1g1n(x, z; θ̂, F̂ ) when n is suﬃciently large.
The ﬁnal step is to prove that θ∗ = θ0 and F ∗ = F0 through the Kullback-Leibler
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inequality. Let
p˜kj =
∑n
i=1 RiI(Xi = xk)B
q
j (Zi)/P (Ri = 1|Yi,Zi,Wi)∑n
i=1RiB
q
j (Zi)/P (Ri = 1|Yi,Zi,Wi)
,
and let F˜ (x, z) = n−1
∑m
k=1
∑n
i=1 I(xk ≤ x,Zi ≤ z)
∑sn
j=1 B
q
j (Zi)p˜kj. By the approxima-
tion theory of B-splines (Schumaker 1981), F˜ (x, z) → F0(x, z) uniformly. Furthermore,
it follows from the deﬁnitions of F̂ and F˜ that F̂ is absolutely continuous with respect to
F˜ . Thus, dF̂ /dF˜ converges uniformly to dF ∗/dF0. By Condition (C.3), F ∗ is continuously
diﬀerentiable with respect to x and z.
By the deﬁnitions of θ̂ and {p̂kj}, we have n−1ln(θ̂, {p̂kj}) ≥ n−1ln(θ0, {p˜kj}), i.e.,
− n−1
n∑
i=1
Ri log
Pθ̂(Yi|Xi,Zi,Wi)
Pθ0(Yi|Xi,Zi,Wi)
− n−1
n∑
i=1
Ri
m∑
k=1
I(Xi = xk)
sn∑
j=1
Bqj (Zi) log
p̂kj
p˜kj
− n−1
n∑
i=1
(1−Ri) log
´
Pθ̂(Yi|x,Zi,Wi)F̂ (dx,Zi)´
Pθ0(Yi|x,Zi,Wi)F˜ (dx,Zi)
≤ 0. (4.29)
The ﬁrst term in expression (4.29) converges to
−E
{
R log
Pθ∗(Y |X,Z,W )
Pθ0(Y |X,Z,W )
}
. (4.30)
By the approximation theory of B-splines (Schumaker 1981),
∑sn
j=1B
q
j (z) log(p̂kj/p˜kj) is
asymptotically equivalent to
log
∑sn
j=1B
q
j (z)p̂kj∑sn
j=1B
q
j (z)p˜kj
= log
dF̂ (x, z)
dF˜ (x, z)
∣∣∣∣∣
x=xk
.
Thus
∑sn
j=1B
q
j (z) log(p̂kj/p˜kj) converges uniformly to log{dF ∗(x, z)/dF0(x, z)}|x=xk . As a
result, the second term in expression (4.29) converges to
−E
{
R log
dF ∗(X,Z)
dF0(X,Z)
}
. (4.31)
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The third term in expression (4.29) converges to
−E
{
(1−R) log
´
Pθ∗(Y |x,Z,W )F ∗(dx,Z)´
Pθ0(Y |x,Z,W )F0(dx,Z)
}
. (4.32)
By combining expressions (4.30), (4.31), and (4.32), we conclude that the Kullback-
Leibler information of the density indexed by θ∗ and F ∗ with respect to the true density is
nonpositive and thus must be zero. Therefore, the two densities are identical almost surely.
For R = 1, this implies that Pθ∗(Y |X,Z,W )F ∗(X,Z) = Pθ0(Y |X,Z,W )F0(X,Z). It
follows from Condition (C.2) that θ∗ = θ0 and F ∗ = F0. Thus, Theorem 1 holds. 
Proof of Theorem 4.2. Let lθ denote the score function for θ0 and lF (h) denote the score
function along the submodel {1 + h(x, z)}dF0(x, z) based on one complete observation
(Y,X,Z,W ), where h ∈ L2(P), P is the probability measure indexed by (θ0, F0), and
E{h(X,Z)} = 0. We have lθ = ∂ logPθ0(Y |X,Z,W )/∂θ and lF (h) = h. For two-phase
studies, the score operators are loθ = Rlθ + (1 − R)E(lθ|Y,Z,W ) and loF = RlF + (1 −
R)E(lF |Y,Z,W ). The information operator is
loθ∗loθ loθ∗loF
loF
∗loθ l
o
F
∗loF
 ,
where loθ
∗ and loF
∗ are the adjoint operators of loθ and l
o
F , respectively. We calculate the
information operator as
loθ
∗loθ = E
{
Rlθ
⊗2 + (1−R)E(lθ|Y,Z,W )⊗2
}
,
loθ
∗loF (h) = l
o
F
∗loθ(h)
T = E [E {Rlθ + (1−R)E(lθ|Y,Z,W )|X,Z}h(X,Z)] , and
loF
∗loF (h) = E(R|X,Z)h(X,Z) + E {(1−R)E(h(X,Z)|Y,Z,W )|X,Z} .
This information operator is the sum of an invertible operator and a compact operator from
the space M ≡ Rd ×BV (Dx,z) to itself, where d is the dimension of θ, and BV (Dx,z) is the
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space of functions with bounded total variation in the support of (X,Z). By Theorem 4.7
of Rudin (1973), the information operator is invertible if it is one to one, or equivalently, the
Fisher information along any nontrivial submodel is nonzero.
Suppose that the Fisher information is zero along some submodel [θ0 + v, dF0(x, z){1 +
h(x, z)}]. Then, the score function along this submodel, i.e., loθTv + loF (h), is zero. We
set R = 1 to obtain lTθ v + lF (h) = 0 for any (Y,X,Z,W ) ∈ C. Speciﬁcally, for any
(yi,x, z,wi) ∈ C, i = 1, 2, we have
{
∂
∂θ
logPθ0(y1|x, z,w1)
}T
v + h(x, z) =
{
∂
∂θ
logPθ0(y2|x, z,w2)
}T
v + h(x, z),
which can be rewritten as a linear equation on v, i.e.,
{
∂
∂θ
logPθ0(y1|x, z,w1)−
∂
∂θ
logPθ0(y2|x, z,w2)
}T
v = 0.
By Condition (C.2), v = 0 and h = 0 with probability one. Thus, the information operator
is invertible. Consequently, there exists a function h such that loF
∗loF (h) = l
o
F
∗loθ, i.e.,
E(R|X,Z)h+ E {(1−R)E(h|Y,Z,W )|X,Z}
=E {Rlθ + (1−R)E(lθ|Y,Z,W )|X,Z} . (4.33)
This means that the least favorable direction for θ0 exists. In addition, by using the argu-
ments in the proof of Theorem 3.4 of Zeng (2005), we can show that h is q-times continuously
diﬀerentiable.
Because (θ̂, F̂ ) maximizes expression (4.24), the derivatives of the log-likelihood function
with respect to  along the submodel (θ̂ + v, dF̂ ) for any v and the submodel {θ̂, dF̂ (1 +
hn)} must be zero, where hn is the projection of h onto the tangent space of the sieve
space. By the approximation theory of B-splines (Schumaker 1981), we have ‖hn − h‖L2 .
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s
−q/dz
n . Therefore, (θ̂, F̂ ) is the solution to the functional Ψn(θ, F ) = 0, where Ψn(θ, F ) =
Ψ1n(θ, F )−Ψ2n(θ, F ),
Ψ1n(θ, F ) = Pn
{
R
∂
∂θ
logPθ(Y |X,Z,W )
}
+ Pn
{
(1−R)
ˆ
∂
∂θ
logPθ(Y |x,Z,W )g2(Y,Z,W ,x;θ, F )F (dx,Z)
}
,
Ψ2n(θ, F ) = Pn {Rhn(X,Z)}
+ Pn
{
(1−R)
ˆ
g2(Y,Z,W ,x;θ, F )hn(x,Z)F (dx,Z)
}
,
Pn is the empirical measure of the sample, and
g2(Y,Z,W ,x;θ, F ) =
Pθ(Y |x,Z,W )´
Pθ(Y |x˜,Z,W )F (dx˜,Z) .
Let Ψ(θ, F ) be the same as Ψn(θ, F ) except that Pn is replaced by P . Clearly, θ̂ satisﬁes
the following equation:
n1/2
{
Ψn(θ̂, F̂ )−Ψ(θ̂, F̂ )
}
= −n1/2Ψ(θ̂, F̂ ). (4.34)
We wish to use Theorem 2.11.22 of van der Vaart and Wellner (1996) to show that
n1/2
{
Ψn(θ̂, F̂ )−Ψ(θ̂, F̂ )
}
= n1/2(Pn − P) {loθ − loF (hn)}+ op(1). (4.35)
Note that the left-hand side of equation (4.35) is an empirical process of the following two
classes of functions indexed by (θ̂, F̂ ):
F1n =
{
R
∂
∂θ
logPθ(Y |X,Z,W ) + (1−R)
ˆ
∂
∂θ
logPθ(Y |x,Z,W )
× g2(Y,Z,W ,x;θ, F )F (dx,Z) : |θ − θ0|+ ‖F − F0‖ ≤ 0
}
;
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F2n =
{
Rhn(X,Z) + (1−R)
ˆ
g2(Y,Z,W ,x;θ, F )hn(x,Z)F (dx,Z) :
|θ − θ0|+ ‖F − F0‖ ≤ 0
}
,
where ‖F − F0‖ is the supreme norm in Dx,z. By Theorem 1 and the approximation theory
of B-splines (Schumaker 1981), it is straightforward to verify that
R
∂
∂θ
logPθ̂(Y |X,Z,W ) + (1−R)
ˆ
∂
∂θ
logPθ̂(Y |x,Z,W )
× g2(Y,Z,W ,x; θ̂, F̂ )F̂ (dx,Z)
→ R ∂
∂θ
logPθ0(Y |X,Z,W ) + (1−R)
ˆ
∂
∂θ
logPθ0(Y |x,Z,W )
× Pθ0(Y |x,Z,W )F0(dx,Z)´
Pθ0(Y |x,Z,W )F0(dx,Z)
= Rlθ + (1−R)E{lθ|Y,Z,W } = loθ,
and
Rhn(X,Z) + (1−R)
ˆ
g2(Y,Z,W ,x; θ̂, F̂ )hn(x,Z)F̂ (dx,Z)
→ Rh(X,Z) + (1−R)
´
h(x,Z)Pθ0(Y |x,Z,W )F0(dx,Z)´
Pθ0(Y |x,Z,W )F0(dx,Z)
= Rh(X,Z) + (1−R)E {h(X,Z)|Y,Z,W } = loF (h)
uniformly in (Y,X,Z,W ).
Clearly, all functions in the classes F1n and F2n are uniformly bounded. We wish to verify
the conditions in Theorem 2.11.22 of van der Vaart and Wellner (1996). We ﬁrst show that
the classes of functions F1n and F2n satisfy the uniform entropy condition. Pick any two
functions from F1n, say f1 and f2, which are indexed by (θ1, F1) and (θ2, F2), respectively.
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The diﬀerence between the two functions is bounded from above by
∣∣∣∣ ∂∂θ logPθ1(Y |X,Z,W )− ∂∂θ logPθ2(Y |X,Z,W )
∣∣∣∣
+
∣∣∣∣ˆ ∂∂θ logPθ1(Y |x,Z,W )g2(Y,Z,W ,x;θ1, F1)(F1 − F2)(dx,Z)
∣∣∣∣
+
∣∣∣∣ˆ { ∂∂θ logPθ1(Y |x,Z,W )− ∂∂θ logPθ2(Y |x,Z,W )
}
× g2(Y,Z,W ,x;θ1, F1)F2(dx,Z)
∣∣∣∣
+
∣∣∣∣ ˆ ∂∂θ logPθ2(Y |x,Z,W ){g2(Y,Z,W ,x;θ1, F1)
− g2(Y,Z,W ,x;θ2, F2)
}
F2(dx,Z)
∣∣∣∣
≡ (i) + (ii) + (iii) + (iv).
By the mean-value theorem, (i) . ‖θ1 − θ2‖. Because the denominator in the expression of
g2(Y,Z,W ,x;θ, F ) is bounded away from zero, we obtain that
(ii) .
ˆ
|F1(x,Z)− F2(x,Z)| dx .
ˆ
|F1(x, z)− F2(x, z)| dxdz.
By the mean-value theorem,
(iii) . ‖θ1 − θ2‖
ˆ
g2(Y,Z,W ,x;θ1, F1)F2(dx,Z) . ‖θ1 − θ2‖ .
Likewise,
(iv) . ‖θ1 − θ2‖+
ˆ
|F1(x, z)− F2(x, z)|dxdz.
Combining the above inequalities for (i), (ii), (iii), and (iv), we have
|f1 − f2| . ‖θ1 − θ2‖+
ˆ
|F1(x, z)− F2(x, z)|dxdz.
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Thus, the Cauchy-Schwartz inequality implies that, for any ﬁnite measure Q,
‖f1 − f2‖L2(Q) . ‖θ1 − θ2‖+
{ˆ
|F1(x, z)− F2(x, z)|2dxdz
}1/2
= ‖θ1 − θ2‖+ ‖F1(X,Z)− F2(X,Z)‖L2(Q˜), (4.36)
where Q˜ is the uniform measure on Dx,z. We conclude that
N{,F1n, L2(Q)) .N(/2, (θ : ‖θ − θ0‖ < 0), | · |}
×N(/2, (F : ‖F − F0‖∞ < 0), L2(Q˜)}, (4.37)
where N(·, ·, ·) denotes the covering number. On the right-hand side of (4.37), the ﬁrst
covering number is O(1/d). The second covering number is O[exp{−2V/(V+2)}], where V is
some positive index. To see the latter result, we observe that (F : ‖F − F0‖∞ < ) is in
the symmetric convex hull of a Vapnik-Chervonenkis class [I{a < (XT,ZT)T ≤ b}: a, b ∈
Rdx+dz ], where dx denotes the dimension of X. The result follows from Theorem 2.6.9 of
van der Vaart and Wellner (1996). Therefore, expression (4.37) implies that F1n satisﬁes
the uniform entropy condition in Theorem 2.11.22 of van der Vaart and Wellner (1996). By
similar arguments and the fact that ‖hn‖L2 . ‖h‖L2 , we can show that F2n also satisﬁes the
uniform entropy condition.
If we replace measure Q by P , then expression (4.36) implies that the functions in F1n
and F2n are Lipschitz continuous with respect to (θ, F ) in the metric deﬁned as
ρ{(θ1, F1), (θ2, F2)} = ‖θ1 − θ2‖+ ‖F1 − F2‖L2(P).
As a result, condition (2.11.21) in Theorem 2.11.22 of van der Vaart and Wellner (1996)
holds. In addition, the total boundedness of the index set (θ, F ) holds due to the precom-
pactness of (θ, F ) under the uniform metric. We have now veriﬁed all of the conditions in
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Theorem 2.11.22 of van der Vaart and Wellner (1996). Thus, equation (4.35) follows from
that theorem.
By combining equations (4.34) and (4.35), we have
−n1/2
{
Ψ1(θ̂, F̂ )−Ψ2(θ̂, F̂ )
}
= n1/2(Pn − P){loθ − loF (hn)}+ op(1), (4.38)
where Ψ1(θ, F ) and Ψ2(θ, F ) are the same as Ψ1n(θ, F ) and Ψ2n(θ, F ), respectively, except
that Pn is replaced by P . The left-hand side of equation (4.38) can be linearized around
(θ0, F0). Speciﬁcally,
Ψ1(θ̂, F̂ ) = Ψ1(θ0, F0) + P{R ∂
2
∂θT∂θ
logPθ∗(Y |X,Z,W )(θ̂ − θ0)}
+P
[
(1−R)
ˆ
∂
∂θ
{
∂
∂θ
logPθ∗(Y |x,Z,W )g2(Y,Z,W ,x;θ∗, F ∗)
}
× (θ̂ − θ0)F̂ (dx,Z)
]
+P
[
(1−R)
ˆ
∂
∂θ
logPθ∗(Y |x,Z,W )
{
∂
∂F
g2(Y,Z,W ,x;θ
∗, F ∗)
× F ∗(dx,Z)
}
(F̂ − F0)
]
,
where ∂/∂F denotes the pathwise derivative, and (θ∗, F ∗) lies between (θ̂, F̂ ) and (θ0, F0).
Similar expansions can be obtained for Ψ2(θ̂, F̂ ). By the approximation theory of B-splines
(Schumaker 1981), we can show that the left-hand side of (4.38) equals
− n1/2 {1 + op(1)}E
{
loθθ(θ̂ − θ0) + loθF (F̂ − F0)− loFθ(hn)(θ̂ − θ0)− loFF (hn, F̂ − F0)
}
− n1/2 {Ψ1(θ0, F0)−Ψ2(θ0, F0)} , (4.39)
where loθθ is the derivative of l
o
θ with respect to θ, l
o
θF (h) is the derivative of l
o
θ with respect
to F along the direction h, loFθ(h) is the derivative of l
o
F (h) with respect to θ, and l
o
FF (h1, h2)
is the derivative of loF (h1) with respect to F along the direction h2.
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Because we have chosen h to be the least favorable direction for θ0 and ‖hn − h‖L2 .
s
−q/dz
n , we have E{loFF (hn, F̂ −F0)} = E{loθF (F̂ −F0)}+O(s−q/dzn ) and E{loFθ(hn)(θ̂−θ0)} =
E{loFθ(h)(θ̂−θ0)}+O(s−q/dzn ). Thus, by Condition (C.5), the ﬁrst term in expression (4.39)
is n1/2Σ(θ̂ − θ0) + O(n1/2s−q/dzn ) = n1/2Σ(θ̂ − θ0) + o(1), where Σ = −E{loθθ − loFθ(h)},
which is an invertible matrix due to the invertibility of the information operator for (θ0, F0).
Because P {R∂ logPθ0(Y |X,Z,W )/∂θ} = 0 and
P
{
(1−R)
ˆ
∂
∂θ
logPθ0(Y |x,Z,W )
Pθ0(Y |x,Z,W )F0(dx,Z)´
Pθ0(Y |x,Z,W )F0(dx,Z)
}
= 0,
the last term in (4.39) equals zero. It follows from equation (4.38) that
n1/2{1 + op(1)}Σ(θ̂ − θ0) + op(1) = n1/2(Pn − P) {loθ − loF (h)} .
Thus, we have established the asymptotic normality in Theorem 4.2. Because Σ−1{loθ −
loF (h)} is the eﬃcient inﬂuence function for θ0, its limiting covariance matrix attains the
semiparametric eﬃciency bound. 
For a given θ, we deﬁne F̂θ as the joint distribution function of (X,Z) that maximizes
ln(θ, {pkj}). By the arguments in the proof of Theorem 4.1, we can show that for any
θ̂ → θ0 in probability, the estimator F̂θ̂ → F0 uniformly. Furthermore, given the existence
of the least favorable directions, we can construct the least favorable model. These two facts
imply that the proﬁle likelihood theory in Murphy and van der Vaart (2000) holds for our
approach. Thus, the inverse of the negative Hessian matrix of the proﬁle likelihood function
is a consistent estimator for the limiting covariance matrix of n1/2(θ̂ − θ0).
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CHAPTER 5: OPTIMAL TWO-PHASE DESIGNS AND FUTURE
RESEARCH
5.1 Optimal Two-Phase Designs
5.1.1 Introduction
Previous research on two-phase studies has largely focused on the inference procedures
rather than the design aspects. An important topic of investigation is the optimal study
design when the primary interest is to estimate the regression coeﬃcients of the expensive
covariates. If a discrete outcome is of primary interest and there are no inexpensive covari-
ates, then it is well known that the case-control design with an equal number of cases and
controls is the most eﬃcient one. When a continuous outcome is of primary interest, two
types of designs are commonly used in practice. The ﬁrst design selects subjects from the
two tails of the outcome distribution in the second phase. We call this design the outcome-
dependent sampling (ODS) design. If the inexpensive covariates are also available in the ﬁrst
phase, then we can ﬁt a marginal model relating the outcome to inexpensive covariates and
use the residuals from the ﬁtted model to select subjects. We call this design the residual-
dependent sampling (RDS) design. Both the ODS and RDS designs have been adopted in
the NHLBI ESP. Speciﬁcally, the ODS design has been adopted in the BMI study and the
RDS design has been adopted in the BP and LDL studies.
Although the design issue is important, little research has been done to study the optimal
design. Recently, Lin et al. (2013) showed that the ODS design is optimal when there is no
inexpensive covariates. For general two-phase studies, it is unclear what the best sampling
strategy is. In this project, we study optimal designs for parametric and semiparametric
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regression problems under general two-phase studies. We derive the eﬃcient information
for estimating the regression coeﬃcients of the expensive covariates under local alternatives.
We compare eﬃciencies between the optimal and existing designs in extensive simulation
studies.
5.1.2 Methods
Let Y be the outcome(s) of interest, X denote the expensive covariate, and Z denote the
vector of inexpensive covariates. The data (Y,X,Z) are assumed to be generated from the
joint distribution Pθ,φ(Y |X,Z)η(X,Z), where Pθ,φ(Y |X,Z) = f{Y |µ(X,Z);φ} is a regres-
sion model indexed by θ = (α, β, γT)T and φ, (α, β, γ) are the regression coeﬃcients in the
linear predictor µ(X,Z) = α + βX + γTZ, φ is a (possibly inﬁnite-dimensional) nuisance
parameter, and η(X,Z) is the joint distribution of X and Z.
If (Y,X,Z) is observed for all n subjects in the study, then it is standard to base inferences
about θ on the conditional distribution of Y given (X,Z), such that the likelihood is
n∏
i=1
Pθ,φ(Yi|Xi, Zi).
Under the two-phase design, however, only (Y, Z) is measured for all n subjects in the ﬁrst
phase, and X is measured for a sub-sample of size n2 in the second phase. Let R indicate, by
the values 1 versus 0, whether the subject is selected for the measurement of X in the second
phase. A key assumption for the two-phase design is that the distribution of R depends on
(Y,X,Z) only through the ﬁrst-phase data (Y, Z). Under this assumption, the data on X are
missing at random, such that the sampling indicators (R1, . . . , Rn) can be omitted from the
likelihood function when estimating θ. Thus, the observed-data likelihood and log-likelihood
take the forms
L(θ, φ, η) =
n∏
i=1
{Pθ,φ(Yi|Xi, Zi)η(Xi, Zi)}Ri
{ˆ
Pθ,φ(Yi|x, Zi)η(x, Zi)dx
}1−Ri
,
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and
l(θ, φ, η) =
n∑
i=1
Ri logPθ,φ(Yi|Xi, Zi) +
n∑
i=1
Ri log η(Xi, Zi)
+
n∑
i=1
(1−Ri) log
ˆ
Pθ,φ(Yi|x, Zi)η(x, Zi)dx,
respectively. Our main interest lies in the inference of β.
Let fµ{Y |µ(X,Z), φ} ≡ ∂ logPθ,φ(Y |X,Z)/∂µ, and fφ(h1) denote the score for φ along
the submodel t→ φt(h1) for one complete observation (Y,X,Z), where h1 ∈ L2(P), P is the
probability measure indexed by (θ, φ, η), and φ0(h1) = φ. Let Uθ ≡ (Uα, Uβ, UTγ )T denote
the score for θ, Uφ(h1) denote the score for φ along the submodel φt(h1), and Uη(h2) denote
the score for η along the submodel {1 + th2(x, z)}η(x, z) under the two-phase design, where
h2 ∈ L02(η). We have
Uα =Rfµ{Y |µ(X,Z), φ}+ (1−R)E [fµ{Y |µ(X,Z), φ}|Y, Z] ,
Uβ =Rfµ{Y |µ(X,Z), φ}X + (1−R)E [fµ{Y |µ(X,Z), φ}X|Y, Z] ,
Uγ =Rfµ{Y |µ(X,Z), φ}Z + (1−R)E [fµ{Y |µ(X,Z), φ}Z|Y, Z] ,
Uφ(h1) =Rfφ(h1) + (1−R)E {fφ(h1)|Y, Z} ,
Uη(h2) =Rh2(X,Z) + (1−R)E [h2(X,Z)|Y, Z] .
The information operator is

U∗θUθ U
∗
θUφ U
∗
θUη
U∗φUθ U
∗
φUφ U
∗
φUη
U∗ηUθ U
∗
ηUφ U
∗
ηUη
 ,
where U∗θ = (U
∗
α, U
∗
β , U
∗
γ ), and U
∗
α, U
∗
β , U
∗
γ , U
∗
φ, and U
∗
η are the adjoint operators of Uα, Uβ,
Uγ, Uφ, and Uη, respectively. Under the null hypothesis β = 0, we have µ(X,Z) = α+γTZ ≡
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µ(Z). Thus, fµ{Y |µ(Z), φ} and fφ(h1) do not depend on X. Consequently, we calculate the
information operator as
U∗αUα =E
(
Rf 2µ{Y |µ(Z), φ}+ (1−R)E [fµ{Y |µ(Z), φ}|Y, Z]2
)
= E
[
f 2µ{Y |µ(Z), φ}
]
,
U∗γUγ =E
[
f 2µ{Y |µ(Z), φ}ZZT
]
,
U∗αUγ =E
[
f 2µ{Y |µ(Z), φ}ZT
]
,
U∗αUβ =E
[
Rf 2µ{Y |µ(Z), φ}X
]
+ E ((1−R)E [fµ{Y |µ(Z), φ}|Y, Z] E [fµ{Y |µ(Z), φ}X|Y, Z])
=E
[
f 2µ{Y |µ(Z), φ}E (X|Z)
]
,
U∗βUγ =E
[
f 2µ{Y |µ(Z), φ}E (X|Z)Z
]
,
U∗βUβ =E
(
Rf 2µ{Y |µ(Z), φ}X2 + (1−R)E [fµ{Y |µ(Z), φ}X|Y, Z]2
)
=E
[
Rf 2µ{Y |µ(Z), φ}X2 + (1−R)f 2µ{Y |µ(Z), φ}E (X|Z)2
]
=E
[
f 2µ{Y |µ(Z), φ}E (X|Z)2
]
+ E
[
Rf 2µ{Y |µ(Z), φ}Var (X|Z)
]
,
U∗αUφ(h1) =E {fµ{Y |µ(Z), φ}fφ(h1)} ,
U∗γUφ(h1) =E {fµ{Y |µ(Z), φ}Zfφ(h1)} ,
U∗βUφ(h1) =E {fµ{Y |µ(Z), φ}E(X|Z)fφ(h1)} ,
U∗φUφ(h1) =f
∗
φfφ(h1),
U∗αUη(h2) =E {E (Rfµ{Y |µ(Z), φ}+ (1−R)E [fµ{Y |µ(Z), φ}|Y, Z] |X,Z)h2(X,Z)}
=E (E [fµ{Y |µ(Z), φ}|Z]h2(X,Z)) = 0,
U∗γUη(h2) =0,
U∗φUη(h2) =0,
U∗βUη(h2) =E {E (Rfµ{Y |µ(Z), φ}X + (1−R)E [fµ{Y |µ(Z), φ}X|Y, Z] |X,Z)h2(X,Z)}
=E (E [Rfµ{Y |µ(Z), φ}|Z] {X − E(X|Z)}h2(X,Z)) ,
U∗ηUη(h2) =E(R|X,Z)h2(X,Z) + E [(1−R)E {h2(X,Z)|Y, Z} |X,Z]
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=E(R|X,Z)h2(X,Z) + E {(1−R)|X,Z}E {h2(X,Z)|Z}
=E(R|Z) [h2(X,Z)− E {h2(X,Z)|Z}] + E {h2(X,Z)|Z} ,
where f ∗φ is the adjoint operator of fφ.
To calculate the eﬃcient information of β, denoted by Iββ, we observe that the score
spaces for (α, γ, φ) and η are orthogonal. Therefore, we have
Iββ =U∗βUβ − 〈M1Uβ, Uβ〉 − 〈M2Uβ, Uβ〉
=E
[
f 2µ{Y |µ(Z), φ}E (X|Z)2
]− 〈M1Uβ, Uβ〉 − 〈M2Uβ, Uβ〉
+ E
[
Rf 2µ{Y |µ(Z), φ}Var (X|Z)
]
,
where
M1 =
[
Uα Uγ Uφ
]
U∗αUα U
∗
αUγ U
∗
αUφ
U∗γUα U
∗
γUγ U
∗
γUφ
U∗φUα U
∗
φUγ U
∗
φUφ

−1 
U∗α
U∗γ
U∗φ
 ,
and M2 = Uη(U∗ηUη)
−1U∗η are the projection operators onto the score spaces of (α, γ, φ) and
η, respectively. Let Iββ0 ≡ E
[
f 2µ{Y |µ(Z), φ}E (X|Z)2
] − 〈M1Uβ, Uβ〉. We observe that Iββ0
is the eﬃcient information for β in the regression model Pθ,φ(Y |X,Z), except that X is
replaced by E(X|Z). Because Iββ0 does not depend on R, it is invariant under any type of
two-phase design.
Next, we calculate 〈M2Uβ, Uβ〉 as follows:
(U∗ηUη)
−1(h2) =E(R|Z)−1 [h2(X,Z)− E {h2(X,Z)|Z}] ,
(U∗ηUη)
−1U∗η (h2) =h2(X,Z)− E {h2(X,Z)|Z} ,
Uη(U
∗
ηUη)
−1U∗η (h2) =R [h2(X,Z)− E {h2(X,Z)|Z}] ,
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M2Uβ =R
(
E [Rfµ{Y |µ(Z), φ}|Z]X + (1−R)E [fµ{Y |µ(Z), φ}|Z] E(X|Z)
− E [Rfµ{Y |µ(Z), φ}X|Z]− E [(1−R)fµ{Y |µ(Z), φ}E(X|Z)|Z]
)
=RE [Rfµ{Y |µ(Z), φ}|Z]X −RE [Rfµ{Y |µ(Z), φ}X|Z]
−RE [(1−R)fµ{Y |µ(Z), φ}E(X|Z)|Z]
=RE [Rfµ{Y |µ(Z), φ}|Z] {X − E(X|Z)},
〈M2Uβ, Uβ〉 =E
{
RE [Rfµ{Y |µ(Z), φ}|Z] {X − E(X|Z)}
× (Rfµ{Y |µ(Z), φ}X + (1−R)E [fµ{Y |µ(Z), φ}X|Y, Z])
}
=E
(
RE [Rfµ{Y |µ(Z), φ}|Z] {X − E(X|Z)}fµ{Y |µ(Z), φ}X
)
=E
(
E [Rfµ{Y |µ(Z), φ}|Z]2 Var(X|Z)
)
.
Consequently,
Iββ = Iββ0 + E
(
E
[
Rf 2µ{Y |µ(Z), φ} − E [Rfµ{Y |µ(Z), φ}|Z]2
∣∣Z]Var (X|Z)) . (5.40)
The design is more eﬃcient if the second term on the right-hand side of equation (5.40) is
larger.
5.1.3 Simulation Studies
We conducted simulation studies to compare the eﬃciencies of diﬀerent designs when the
outcome is continuous. Speciﬁcally, we set Z to be a Bernoulli random variable with mean
0.5, and X to be a Bernoulli random variable with mean p0 or p1 depending on whether
Z = 0 or 1. We generated the outcome from the linear model: Y = βX + γZ + 1, where
1 is a standard normal random variable independent of X and Z. We set n = 4000 and
considered three types of two-phase designs. The ODS design selects 200 and 200 subjects
with extremely large and small values of Y, respectively; the RDS design selects 200 and 200
subjects with extremely large and small values of Y −γ̂Z, respectively; and the optimal design
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selects 200 and 200 subjects with extremely large or small values of
√
Var(X|Z)(Y − γ̂Z),
respectively, where Var(X|Z = j) = pj(1 − pj), j = 0, 1. For benchmark comparisons, we
included a forth design where the ﬁrst-phase information is ignored and a simple random
sample (SRS) of 400 subjects is selected.
The relative eﬃciencies between each of the three types of two-phase designs and the SRS
design are shown in Table 5.28. We can see that all three designs are much more eﬃcient
than the SRS design. When Z has no eﬀect on Y, the ODS design is as eﬃcient as the RDS
design. When Z has eﬀects on Y, the RDS design is more eﬃcient than the ODS design.
When Var(X|Z) is a constant, the RDS design is as eﬃcient as the optimal design. When
Var(X|Z) depends on Z, the optimal design is substantially more eﬃcient than the RDS
design.
Table 5.28: Eﬃciency Comparisons Between the ODS, RDS, and Optimal Designs
SE of β̂ RE
p0 and p1 β γ SRS ODS RDS Optimal ODS RDS Optimal
p0 = p1 = 0.7 0.0 0.0 0.110 0.053 0.053 0.053 4.25 4.32 4.32
0.5 0.110 0.059 0.053 0.053 3.47 4.32 4.32
1.0 0.110 0.078 0.053 0.053 1.99 4.32 4.32
0.3 0.0 0.108 0.054 0.054 0.054 4.01 3.98 3.98
0.5 0.108 0.059 0.054 0.054 3.34 3.98 3.98
1.0 0.108 0.080 0.054 0.054 1.82 3.98 3.98
p0 = 0.5, p1 = 0.9 0.0 0.0 0.125 0.060 0.060 0.056 4.29 4.29 5.05
0.5 0.125 0.069 0.060 0.056 3.34 4.29 5.05
1.0 0.125 0.093 0.060 0.056 1.80 4.29 5.05
0.3 0.0 0.119 0.061 0.061 0.055 3.79 3.81 4.72
0.5 0.119 0.070 0.061 0.055 2.86 3.81 4.72
1.0 0.119 0.098 0.061 0.055 1.48 3.81 4.72
NOTE: SE is standard error; RE is the empirical variance of β̂ under the two-phase
design over that under the SRS design.
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5.2 Future Extensions
5.2.1 Eﬃcient Inference Under General Two-Phase Sampling
In many epidemiological studies, the covariates of primary interest involve biochemical
or genetic analysis of blood specimens or extraction of detailed exposure histories and thus
are prohibitively expensive to measure in large studies. Two-phase designs that concen-
trate resources on where there is the greatest amount of information are extremely useful
in this setting. The NHLBI ESP and CHARGE TSS are two recent examples. It is not
hard to envision that many large-scale studies will adopt two-phase designs. I am in the
progress of extending my research on eﬃcient semiparametric inference under general two-
phase sampling to diﬀerent types of outcomes, including combinations of continuous and
discrete outcomes, longitudinal outcomes, and censored time-to-event outcomes. I will study
the theoretical properties and ﬁnite sample performance of each of these extensions. Another
important direction worth pursuing is the analysis of secondary outcomes that are not used
for sampling but are correlated with the primary outcome(s) used for sampling. To popular-
ize our methods and facilitate broad collaborations, I will develop computationally eﬃcient
software packages that are capable of handling large datasets, including whole-exome and
whole-genome sequencing studies.
5.2.2 Optimal Two-Phase Designs
I will continue my research on optimal two-phase designs. We have derived the eﬃcient
information for estimating the regression coeﬃcients of the expensive covariates. We will use
this general result to study the optimal design for a number of scenarios, including binary
outcomes with inexpensive covariates, multiple continuous outcomes of equal interest, longi-
tudinal outcomes with interest either in the baseline eﬀect or the trend eﬀect, and censored
time-to-event outcomes. It would be also of interest to study the optimal design when the
interaction eﬀect between expensive and inexpensive covariates is of primary interest.
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